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BD is a severe and highly prevalent psychiatric illness characterized by oscillating mood 
episodes, where patients express either depressed mood, anhedonia, decreased activation 
along with concentration difficulties and sleep disturbances, or elevated mood with 
hyperactivity and loss of inhibitions. Between mood episodes, patients return to a relatively 
normal state of functioning without mood symptoms. Previous research on underlying 
neuronal mechanisms has led to a model of neuronal dysfunction in BD which states that BD 
arises from disruption in early development within brain networks that modulate emotional 
behavior. These abnormalities in the structure and function of key emotional control networks 
then lead to decreased connectivity among ventral prefrontal networks and limbic brain 
regions. This in turn creates a loss of emotional homeostasis, putting bipolar patients at risk 
for developing extreme mood states and switching among mood states. Two core components 
for BD have been identified, a hyperactive emotion processing system and a hypoactive 
cognitive functions system. It is controversial whether these deficits are still detectable in 
euthymia, so it is unclear if hyper- and hypoactivations represent state or trait-like 
characteristics. The aim of this study was to research both core components of BD with a 
paradigm eliciting differential activations in both cognitive and emotion processing networks. 
For this, an emotional word working memory paradigm was constructed to test for differences 
between manic, depressive, and remitted patients as well as a healthy control group. 
Differences were assessed in behavior, brain activation (as a correlate for the hypoactive 
cognitive functions system), measured with near-infrared spectroscopy (fNIRS), and 
electrophysiological changes in the late positive potential (as a correlate for the hyperactive 
emotion processing system), an event-related potential (ERP) measured with 
electroencephalography. 47 patients in the acutely ill phase and 45 healthy controls were 
measured. Of the 47 patients, 18 returned to the clinic for a second testing while in remission 
for at least 3 months. Acutely ill patients were classified into 4 groups according to their 
disorder status: a mildly depressed group, a depressed group, a manic group, and a mixed 
group along DSM-IV criteria. Analyses were calculated for 3 load conditions (1-back, 2-back 
and 3-back) and 3 valence conditions (negative, neutral, positive) for behavioral measures 
reaction time and omission errors, for brain activation and event related potential changes. 
Results indicate that ill patients differed from controls in their behavioral performance, but the 
difference in performance was modulated by the mood state they were in. Depressed patients 
showed the most severe differences in all behavioral measures, while manic and mixed 
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patients differed from controls only upon different valence conditions. Brain activation 
changes were most pronounced in mildly depressed and manic patients, depressed patients 
and mixed patients did not differ as much from controls. ERP changes showed a significant 
difference only between mixed patients and controls, where mixed patients had an overall 
much higher ERP amplitude. When remitted patients were compared to controls, no 
differences in behavior, brain activation or ERP amplitude could be found. However, the 
same was true for differences in patients between acutely ill and remitted state. When looking 
at the overall data, the following conclusion can be drawn: assuming that the brain activation 
seen in the prefrontal cortex is part of the dorsal cognitive system, then this is the 
predominantly disturbed system in depressed patients who show only small changes in the 
ERP. In contrast, the predominantly disturbed system in manic and mixed patients is the 
ventral emotion processing system, which can be seen in a hyper-activation of ERP related 
neural correlates in mixed and hypo-activated neural correlates of the LPP in manic patients. 
When patients are remitted, the cognitive system regains temporary stability, and can be 
compared to that of healthy controls, while the emotion processing system remains 





Die bipolare Störung ist eine schwere und hochprävalente psychiatrische Erkrankung, welche 
gekennzeichnet ist durch oszillierende Stimmungsepisoden, in denen Patienten entweder unter 
Anhedonie leiden, über Aktivitätsverlust und Konzentrationsstörungen klagen und 
Schlafstörungen haben, oder in deutlich aufgehellter Stimmung sind, hyperaktiv werden und 
soziale Hemmungen verlieren. Zwischen diesen Stimmungs-extremen durchlaufen die 
Patienten Phasen mit Stimmungsnormalisierung, oft ohne weitere schwere kognitive Defizite. 
Bisherige Studien über die zugrundeliegenden neuronalen Mechanismen haben ein Model 
hervorgebracht, welches von einer Störung der frühen Entwicklung in Hirnregionen, die 
emotionales Verhalten regulieren, ausgeht. Diese Anomalitäten in Struktur und Funktion von 
Kernkomponenten der Emotionskontrolle führen dann zu einem Verlust der Konnektivität in 
ventralen präfrontalen und limbischen Netzwerken. Dieser Verlust wiederum verursacht einen 
Verlust an emotionaler Homöostase, welches die Patienten dem Risiko aussetzt, extreme 
Stimmungsschwankungen zu erfahren. Zwei Kernkomponenten der bipolaren Störung wurden 
aufgrund dieses Modells definiert: ein hyperaktives Emotionsverarbeitungssystem, und ein 
hypoaktives kognitives Funktionssystem. Es ist bis jetzt nicht klar, in welcher Art und Weise 
diese emotionalen und kognitiven Dysfunktionen auch im euthymen Zustand weiterbestehen. 
Das Ziel dieser Studie war es, die beiden Kernkomponenten der Dysfunktion in der bipolaren 
Störung mit einem Paradigma zu untersuchen, welche beide Komponenten erfasst. Es wurde 
dazu ein emotionales Arbeitsgedächtnis Paradigma entwickelt, um Unterschiede zwischen 
akut kranken Patienten, gesunden Kontrollen und denselben Patienten im remittierten Zustand 
zu erfassen. Die Unterschiede sollten als Unterschiede der Reaktionszeit und 
Auslassungsfehler im Verhalten erfasst werden, ebenso als Unterschiede der Hirnaktivierung, 
gemessen mit funktionaler Nah-Infrarot Spektroskopie, und als Unterschiede in einem 
neurophysiologischen Korrelat, des „Late Positive Potential“ (LPP) betrachtet werden. 47 
Patienten wurden rekrutiert, und eingeteilt nach dem Pol ihrer aktuellen Stimmungsepisode in 
schwer depressive Patienten, Patienten mit einer mittleren Depression, manische Patienten 
und Patienten im Mischzustand. Von den 47 akut kranken Patienten konnten 18 im 
remittierten Zustand wiederum gemessen werden. Anschließend wurden Gruppenunterschiede 
in 3 kognitiven Variablen (1-back, 2-back und 3-back) und 3 emotionalen Variablen (positiv, 




Die Ergebnisse zeigen dass akut kranke Patienten sich in ihrem Verhalten von Kontrollen 
unterscheiden, jedoch wurden diese Unterschiede von der Art der aktuellen 
Stimmungsepisode moduliert. Schwer depressive Patienten zeigten die deutlichsten 
Unterschiede, während manische Patienten und Patienten im Mischzustand nur in den 
emotionalen Variablen Unterschiede zeigten. Die Hirnaktivierungsunterschiede waren am 
deutlichsten zwischen Patienten mit einer mittelschweren Depression und manischen 
Patienten, bei schwer depressiven Patienten und Patienten im Mischzustand waren diese 
Unterschiede deutlich schwächer ausgeprägt. Die LPP Analysen zeigten deutliche 
Unterschiede nur zwischen Patienten mit Mischbild und Kontrollen, die Patienten hatten 
hierbei eine deutlich erhöhte LPP Amplitude. Die Untersuchung der Unterschiede zwischen 
remittierten Patienten und Kontrollen ergab keine signifikanten Ergebnisse, ebenso die 
Analysen der Unterschiede zwischen akut kranken und remittierten Patienten. Alle Ergebnisse 
zusammengenommen, ergibt sich folgendes Bild: Wenn die Hirnaktivierung als Korrelat 
eines gestörten kognitiven Systems gesehen werden kann, und die LPP als Korrelat eines 
gestörten Emotionsverarbeitungssystems, dann könnte für Patienten mit einer mittleren oder 
schweren Depression das kognitive System das Hauptproblem darstellen, während für 
manische Patienten und Patienten im Mischzustand das Emotionsverarbeitungssystem das 
dominante Problem darstellt. Wenn die Patienten dann remittieren, erhält das kognitive 
System eine vorübergehende Stabilität zurück, das Emotionsverarbeitungssystem jedoch 
bleibt dysfunktional, und ist verantwortlich für die bestehenden emotionalen und kognitiven 




1.1. Bipolar Disorder 
Bipolar Disorder (BD) is a severe and, with a lifetime prevalence of 2.4% (Merikangas et al., 
2007), a widely distributed psychiatric disorder. It affects the patient’s mood, thoughts and 
activation levels, resulting either in a depressive episode, or ending in hypomania or mania. 
Both of these mood oscillations have to occur at least once and have to fulfill the diagnostic 
criteria of the International Classification of Diseases (ICD-10) (WHO, 1992) or the 
Diagnostic and Statistical Manual (DSM-IV) (APA, 2000), for a full account please see the 
appendix. In a depressive episode, the main symptoms include, among others, depressed 
mood, blunted activation, negative thoughts, concentration difficulties. It can even lead to 
suicidal ideation and has to be present for at least 2 weeks to justify the diagnosis. A manic 
episode is marked by elevated mood independent of the current situation, heightened 
confidence, pressured speech, hyperactivity, can be as bad as involving psychotic symptoms, 
and has to last at least a week. A hypomanic episode is characterized the same way, but is not 
severe enough to compromise work or social functioning. Symptoms can also occur 
simultaneously, patients in a so called mixed episode report for example thought racing and 
hyperactivity as well as a depressed mood and even suicidal ideation. It is characteristic that 
patients with mixed episodes have a heightened suicide risk (McElroy et al., 1992; Swann et 
al., 2007).  
A number of other psychiatric disorders share symptoms with BD, making a clear distinction 
between these disorders sometimes difficult (Bromet et al., 2011; Laursen, Agerbo, & 
Pedersen, 2009; Tsuang, Woolson, Winokur, & Crowe, 1981). For example, attention deficit 
hyperactivity disorder (ADHD) also includes mood variability, recklessness, impulsivity and 
of course, hyperactivity as core symptoms, and can therefore be hard to be distinguished from 
hypomania. Disorders from the schizophrenic spectrum (such as schizophrenia, 
schizoaffective disorder or single psychotic episodes) also include cognitive deficits, 
psychotic symptoms, reduced activation levels, or thought racing as symptoms and can be 
mistaken for symptoms of a bipolar episode. Finally, major depressive disorder (MDD) is 
practically indistinguishable from BD during a depressive episode, resulting in incorrectly 
diagnosed patients. However, the correct diagnosis of a psychiatric disorder is crucial to the 
treatment effectiveness. It might be therefore necessary to define BD in more than just the 
symptomatic way.  
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In between phases, patients arguably recover completely from their mood and somatic 
symptoms, as well as from their cognitive dysfunctions. The evidence covering the recovery 
of patients is controversial. Some research shows remaining cognitive deficits during 
remission (Malhi et al., 2007; Mann-Wrobel, Carreno, & Dickinson, 2011; Martinez-Aran et 
al., 2004), while other research hints at complete recovery and suspects incorrect 
classification of patients as the underlying mechanism driving evidence for cognitive deficits 
in BD (Iverson, Brooks, Langenecker, & Young, 2011; Strakowski et al., 2012) . Indeed there 
are considerations arguing that patients who do not fully recover from their mood and 
cognitive pathology might be a different group of patients altogether and should not be mixed 
up with bipolar patients, whose core feature then would be the complete recovery between 
episodes (Altshuler et al., 2004; Aminoff et al., 2013; Bora, Yucel, & Pantelis, 2010; Bourne 
et al., 2013; Iverson, et al., 2011; Martino et al., 2008). 
1.2. Pathophysiology 
The origins of BD, like in many other psychiatric disorders, remain essentially unknown. 
Several hypotheses have been stated, claiming to explain the underlying molecular 
mechanisms of BD. BD therefore likely arises from the complex interaction of multiple 
susceptibility genes and environmental factors, which result in changes in intracellular 
signaling cascades, leading to modifications of synaptic number and strength, modeling of 
axonal and dendritic architecture and variations in neurotransmitter release. These changes 
then add up to form the phenotype. Which signaling cascades, neurotransmitters, and 
neuronal architecture changes are involved, can be studied with several different tools, such as 
genetic studies, research in neuroanatomy changes, neuroimaging methods, and research on 
neurotransmitter systems and neural networks (Strakowski, et al., 2012). 
1.2.1. Genetic risk factors 
Among psychiatric disorders, BD has one of the highest heritability rates of up to 75% 
(Cross-Disorder Group of the Psychiatric Genomics, 2013). Over the years, many studies 
have been published with assumed associations of BD with genetic polymorphisms. 
According to Seifuddin et. al (2012), 362 genes were tested in 487 studies, 50 of which were 
researched by at least three studies. The most widely studied gene was the serotonin 
transporter gene (SLC6A4), followed by the gene coding for the serotonin transporter 2A 
(HTR2A). However, results remain inconclusive (Seifuddin, et al., 2012). Only four of those 
genes, BDNF, DRD4, DAOA, and TPH1, were found to be nominally significant, however 
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none survived the correction for multiple testing. On the other hand, genome-wide studies 
using microarrays provided the first hits still significant at the genome-wide level, including 
variants in genes involved in calcium signaling such as CACNA1C.  However, many of the 
investigated polymorphisms are intronic or intergenic, and the functionality of these is, at 
most, speculative. The solution to this problem is again discussed controversially. While some 
groups argue for more atheoretical genome-wide approaches (Cross-Disorder Group of the 
Psychiatric Genomics, 2013; Seifuddin, et al., 2012), it could also be argued that we need 
better theories about the neuronal mechanisms underlying the disorder, to establish molecular 
pathways involved, to find the common genetic linkages between bipolar patients.  
1.2.2. Immunology and neuroendocrinology 
A review by Langdan and McDonald (2009) has highlighted persisting neurobiological trait 
abnormalities in BD patients. The first system reviewed involves cytokines and related 
secretory products, which modulate immune function. Cytokines regulate growth, 
differentiation and function of many cells. They can be classified as pro-inflammatory or anti-
inflammatory. In BD, the pro-inflammatory cytokine production seems to be increased across 
all phases of illness, even though pro-inflammatory processes are especially heightened 
during acute worsening of the disorder (Langan & McDonald, 2009). The hypothalamic-
pituitary-adrenal axis (HPA) also seems to be involved in BD in an analogous fashion as it is 
the case in MDD. The glucocorticoid resistance coupled to that HPA axis dysfunction may be 
caused by known susceptibility genes for the illness (Langan & McDonald, 2009). 
1.2.3. Molecular biology 
Changes on the molecular level in BD involve signal transduction pathways and coordination 
of the cellular responses. Components of these pathways that have been researched are 
multifold. Cyclic adenosine monophosphate (cAMP) regulates many cellular functions, 
including metabolism and gene transcription through the activation of protein kinase A 
(PKA). Activated PKA phosphorylates other protein substrates, including cAMP-response 
element-binding protein (CREB). CREB is a transcription factor that provides a critical link 
between signal transduction and the expression of potentially relevant target genes, including 
the neuroprotective brain-derived neurotrophic factor (BDNF). The review paper shows 
evidence that PKA levels are increased permanently in BD. BDNF levels vary with the 
changing episodes and with the treatment, but studies could not show that BDNF levels are 
reduced as a trait feature of BD. G-Proteins, which are also involved in the cAMP signal 
pathway, provide the link between neurotransmitter binding and subsequent signaling 
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cascades.  Studies researching G-proteins are controversial, while some suggest increased 
levels in all phases of the disorder, while others find a normalization of receptor-G-protein 
coupling with Lithium or valproic acid treatment. (Langan & McDonald, 2009; Schloesser, 
Huang, Klein, & Manji, 2007). Another signaling cascade involves the activation of the 
phosphoinositide second messenger system. Studies report state related abnormalities in 
phosphatidylinositol 4,5-bisphosphate levels and phospholipase C activity in BD. 
Calcium ions are also involved in the mediation of synaptic plasticity, cell survival, 
exocytosis and cell death. Intracellular calcium signaling and homeostasis are regulated in a 
complex manner that includes extracellular entry, release from intracellular stores, specific 
uptake into organelles and binding to proteins. Calcium homeostasis seems altered across all 
mood states in BD (Langan & McDonald, 2009; Schloesser, et al., 2007). 
1.2.4. Dopamine system 
The dopamine system has been implicated in BD for many years (Anand et al., 2011; 
Andreazza & Young, 2013; Cousins, Butts, & Young, 2009). Four major pathways of 
dopamine neurotransmission have been identified in the human brain. The tuberoinfundibular 
pathway is restricted to the hypothalamus and regulates some functions of the anterior 
pituitary gland. The nigrostriatal pathway originates in the substantia nigra and projects to the 
dorsal striatum, with an established role in the motor system (Volkmann, Daniels, & Witt, 
2010). The mesolimbic pathway stems from the ventral tegmental area (VTA) and terminates 
in the ventral striatum, hippocampus, and septum. The mesocortical pathway also originates 
in the VTA but projects more widely to the frontal and temporal cortices. These pathways 
modulate domains such as impulsivity and attention, reward seeking, emotional processing, 
working memory, and executive functions (Aron, Behrens, Smith, Frank, & Poldrack, 2007; 
Chudasama & Robbins, 2006). Considering that all of these functions are impaired in BD, and 
that a main class of medication for BD (i.e., antipsychotics) affects the dopamine system, a 
connection between BD and the dopamine system can well be assumed.  
However, studies researching the connection between monoamine neurotransmitters and BD 
have been declining in the last years. The main reason for this again might be the 
heterogeneity of research methods, leading to contradicting evidence. The fact that 
antidepressant and antipsychotic medication are effective only after days to weeks of 
application, suggests that, while dysfunctions in the monoaminergic neurotransmitter systems 
are likely to play an important role in mediating some symptoms of BD, it might represent 
downstream effects of other, more primary abnormalities in signaling pathways. Another 
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reason for the loss of interest in dopaminergic research might be that this transmitter system is 
affected in many other psychiatric disorders and might therefore represent a common pathway 
at the end of a multitude of causes leading to a psychiatric disease.  
1.2.5. Neuroanatomy 
Post mortem studies in BD find a decrease in the density of neurons in several brain regions, 
for example in the prefrontal cortex (PFC), the anterior cingulate cortex (ACC), the 
hippocampus, the hypothalamus, and the amygdala (Benes, Todtenkopf, & Kostoulakos, 
2001; Benes, Vincent, & Todtenkopf, 2001; Bezchlibnyk et al., 2007; Manaye et al., 2005; 
Rajkowska, Halaris, & Selemon, 2001). Other studies described a low glial cell number and 
size in the dorsolateral PFC in BD (Ongur, Drevets, & Price, 1998). One study even found 
that mood stabilizers might protect glia cells from the adverse effects of BD in the amygdala 
(Bowley, Drevets, Ongur, & Price, 2002). Taken together, this suggests that BD might be 
associated with neuronal and glial cell impairment (Andreazza & Young, 2013; Gigante et al., 
2011). 
Structural imaging studies are more controversial. In an extensive review, Savitz and Drevets 
(Savitz & Drevets, 2009) discuss neuroimaging findings in BD. Computed tomography and 
magnetic resonance imaging have revealed structural abnormalities in the brains of patients 
with BD. While overall gray matter volumes did not differ between BD patients and healthy 
controls (Brambilla et al., 2001), the literature hints at region specific reductions. The most 
consistent finding in that regard is possibly that of increased amygdalar volume in patients 
with BD (Savitz & Drevets, 2009). Findings in other areas are more diverse. Hippocampal 
volume is found to be reduced in some studies, others find no differences in volume between 
controls and BD patients. The same is true for caudate and putamen volumes, even if post 
mortem studies have shown volumetric differences (Savitz & Drevets, 2009). However, the 
striatum has been found to be enlarged in BD patients. To make matters more complicated, 
the striatal volume seems to decrease over time and with an increasing disease load. Evidence 
for ventricular enlargement is again mixed.  
White matter hyperintensities (WMH) have been reported in BD, as well as grey matter 
volume reductions in the PFC, which have been consistently found in patients with BD. 
However, none of the findings mentioned above are entirely consistent, with findings 
contradicting each other in each region mentioned.  
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The same is even more so true for functional imaging studies. These studies are mostly 
functional MRI (fMRI) studies, and either report resting state measurements or measurements 
during cognitive and emotional tasks. Many studies have reviewed the massive amount of 
data produced over the years (Cerullo, Adler, Delbello, & Strakowski, 2009; C. H. Chen, 
Suckling, Lennox, Ooi, & Bullmore, 2011; Houenou et al., 2011; Keener & Phillips, 2007; 
Kempton, Geddes, Ettinger, Williams, & Grasby, 2008; Phillips & Vieta, 2007; Savitz & 
Drevets, 2009; Strakowski, et al., 2012; Strakowski, Delbello, & Adler, 2005). These reviews 
show that mainly 2 dimensions of BD are being studied in BD: emotion dysregulation, and 
with it the regions that are involved in emotion processing and regulation; and cognitive 
deficits occurring in BD. Studies demonstrated increases in activation in several different 
areas associated with emotion processing, such as the amygdala, orbitofrontal cortex, and a 
ventral limbic pathway involving the ventral striatum and the thalamus. On the other hand, 
studies on cognition report decreased activation in areas such as the dorsolateral and 
ventrolateral PFC, and the dorsal ACC.  These areas are mainly associated with cognitive 
control and executive functioning, and reflect the neuropsychological symptoms that patients 
describe.  
This has led to a model of dysfunction in emotion processing and cognitive deficits 
underlying BD, which is characterized by a hyperactive emotional regulation system and a 
hypoactive cognitive functions system. It is controversial whether these deficits are still 
detectable in euthymia, so it is unclear if hyper- and hypoactivations represent state or trait-
like characteristics.  The only consistent finding is that of a hypoactive PFC in all phases of 
the disorder. The current consensus model therefore is one that arises from disruption in early 
development within brain networks that modulate emotional behavior. These abnormalities in 
the structure and function of key emotional control networks then lead to decreased 
connectivity among ventral prefrontal networks and limbic brain regions. This in turn creates 
a loss of emotional homeostasis, putting bipolar patients at risk for developing extreme mood 




1.3. Executive dysfunctions and emotion processing in BD 
1.3.1. Emotions and emotional dysfunction in BD 
Emotional dysfunction is one of the core symptoms of BD. Patients experience mood swings 
ranging from an elevated mood in mania, to irritation, to a depressed mood in a depressive 
phase. To understand how these mood swings arise, one has to first understand how emotions 
arise in healthy humans. 
1.3.2. Emotions 
Emotions can be defined in many ways.  Here, the two most common definitions will be 
described (Gazzaniga, Ivry, Mangun, & Steven, 1998). One way is to list basic emotions, 
which are limited by the way they are expressed universally in a human face (Ekman & 
Friesen, 1971). Ekman and Friesen distinguished 6 basic human expressions translating to 6 
basic emotions: anger, fear, disgust, happiness, sadness and surprise. Emotions can also be 
classified into dimensions of emotion. Emotions are not discrete states of being, but rather 
defined as reactions to stimuli and events. These reactions can be characterized by two 
factors: valence (pleasant-unpleasant) and arousal (low intensity-high intensity). Emotions 
then exist within a continuum of reactions (Osgood, 1957). Alternatively, emotions are 
classified based on the goals they motivate (Davidson, Ekman, Saron, Senulis, & Friesen, 
1990). These goals can either motivate us to approach in situations or withdraw from 
situations and therefore define, within a continuum, the emotions we feel.  
Current models of emotions state that “…emotions are valenced responses to external stimuli 
and/or internal mental representations that involve changes across multiple response systems, 
are distinct from moods in that they often have identifiable objects or triggers, can be either 
unlearned responses to stimuli with intrinsic affective properties, or learned responses to 
stimuli with acquired emotional value and can involve multiple types of appraisal processes 
that assess the significance of stimuli to current goals that depend upon different neural 
systems.”, taken from Ochsner & Gross, (2005) (Cacioppo, Berntson, Larsen, Poehlmann, & 
Ito, 2000; Davidson, 2000; Kevin N Ochsner & Feldman Barrett, 2001; K. N. Ochsner & 
Gross, 2005; Phillips et al., 2003a; Scherer, Schorr, & Johnstone, 2001). 
1.3.3. Emotion processing 
As early as 1937, researchers have been proposing theories considering how emotions are 
processed in the brain, when James Papez introduced his theory about a circuit in the brain 
responsible for emotional reactions. He included the hypothalamus, the anterior thalamus, the 
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cingulate gyrus, and the hippocampus in this circuit, later called the “Papez Circuit”, which 
later also contained the amygdala and the orbitofrontal cortex and was called the limbic 
system. Today, the amygdala and the orbitofrontal cortex are the main focus of emotion 
processing research (Adolphs, 2002).  
The amygdala is possibly the most often implicated brain structure when it comes to emotion 
processing. The amygdala is stated to receive input relevant for emotion processing via two 
mechanisms: a subcortical route via the superior colliculus and the pulvinar thalamus, and a 
cortical route via the visual cortex (Adolphs, 2002; LeDoux, 1996). The subcortical, “low 
road”, is activated as a fast response to emotionally relevant stimuli, and is activated even 
when the emotional stimulus is presented only subliminally (Morris, Ohman, & Dolan, 1999; 
Ohman, Lundqvist, & Esteves, 2001), whereas the cortical “high road” is activated later and 
represents the conscious processing of emotional stimuli. This activation of the amygdala is 
hypothesized to be modulated by the orbitofrontal cortex (Etkin, Egner, & Kalisch, 2011) and 
dysfunctions within these pathways underlie the psychopathology of emotional processing 
(Ohman & Mineka, 2001).  
The orbitofrontal cortex is hypothesized to have multiple functions, but all relate to emotion, 
such as recognition of emotion, social and emotional decision making, control of the 
amygdala responses, and emotional learning (Adolphs, 2002; Gazzaniga, et al., 1998; Phan, 
Wager, Taylor, & Liberzon, 2002). 
However, new research suggests that the picture is not as clear. Luiz Pessoa and Ralph 
Adolphs (Pessoa & Adolphs, 2010) suggest that the amygdala is not a processing organ, but 
rather fulfills a modulatory role in a wide array of networks all processing emotional 
information. It serves to allocate processing resources to emotionally relevant stimuli. They 
also state that the cortex is well capable of fast processing of stimuli and therefore a low road 
is not needed.  
Accordingly, Phillips et al. (Phillips, et al., 2003a) synthesize animal and human studies on 
emotion regulation and suggest the following model: There are two neural systems processing 
emotion: a ventral and a dorsal system. The ventral system includes the amygdala, insula, 
ventral striatum, and ventral regions of the anterior cingulate gyrus and PFC. It is important 
for the identification of the emotional significance of environmental stimuli and the 
production of affective states, as well as automatic regulation and mediation of autonomic 
responses to emotional stimuli. The dorsal system consists of the hippocampus, dorsal regions 
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of the anterior cingulate gyrus, and the PFC. Here, cognitive processes are integrated with and 
can be biased by emotional input. This in turn is important for the performance of executive 
functions, including selective attention, planning, and effortful rather than automatic 
regulation of affective states. These two systems interact with one another and dysfunctions in 
either system may underlie psychiatric disorders expressing emotional dysfunction.  
Another model of emotion processing has been postulated by Jaak Panksepp, who states 
emotional feelings are organized within primitive subcortical regions of the brain. These 
networks can be distinguished in an anxiety network and a seeking network. In bipolar 
disorder, these postulated networks are dysfunctional, meaning that while in mania, the 
seeking network is overactive, in depression, the anxiety network is overactivated. The 
seeking network in Panksepp’s model corresponds to the medial forebrain bundle and a major 
dopamine-driven, self-stimulation reward circuitry, which projects from the ventral midbrain 
to the nucleus accumbens to the medial frontal cortex (Panksepp, 1998, 2010). 
1.3.4. Emotional dysfunction in BD 
The literature on emotional dysfunction in BD is vast and extensive, this chapter will 
therefore not be comprehensive. Phillips et al. (2003b) developed a model for understanding 
the neurobiology of emotion perception in BD based on their model of emotion perception in 
healthy humans (for details, see Figure 1). They conclude that a predominantly ventral system 
is important for the identification of the emotional significance of a stimulus, and the 
production of an affective state. A predominantly dorsal system is important for the effortful 
regulation of the resulting states.  
 
 
Figure 1. Schematic diagram depicting neural structures important for emotion perception 




The interplay between these two systems is disrupted in BD, as can be seen in Figure 2. 
Enlarged rather than decreased amygdalar volumes and enhanced rather than reduced activity 
within the ventral system suggest a dysfunctional increase in the sensitivity of this system to 
identify emotional significance and produce affective states. Impaired effortful regulation of 
subsequent emotional behaviors might result from decreases in prefrontal cortical volumes 
and activity within the dorsal system.  
 
 
Figure 2. Schematic model for the neural basis of the observed deficits in emotion perception 
and behavior, and the relationship between these and the symptoms of BD 
(Phillips, et al., 2003b) 
Interestingly, later reviews conclude the same dysfunctionality. Green et al. (2007) conclude 
that a growing body of research implicates an inhibitory role of PFC and cingulate brain areas 
that exert cognitive control upon sub-cortical and cortical emotion generation systems. This 
inhibitory role, however, fails in patients with BD. Townsend and Altshuler (2012) understate 
this model in their review by stating that the reviewed studies reveal that amygdala activation 
varies as a function of mood state, while the PFC remains persistently hypoactivated across 
mood states. They imply that emotional dysregulation and lability in mania and depression 
may reflect disruption of a frontal-limbic functional neuroanatomical network. Wessa and 
Linke (2009) introduce a model of emotion processing and then give evidence for a disruption 
of each module of this model, concluding that many studies have given evidence for the 
overactivation of a ventral system and the underactivation of a dorsal system leading to a 
dysfunctional emotion processing and eventually to symptoms of BD. However, they also 
point out that very little attention has been paid to the last part of the emotion processing: 
emotion regulation as a function of the dorsolateral prefrontal cortex (dlPFC). This has also 
been pointed out in an extensive review by Banich et al. (2009), who state that the two lines 
of research outlined in BD research, namely the one on cognitive dysfunctions and the one on 
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emotional processing, have been researched in healthy controls as well, and seemingly are 
independent from each other. However, in recent years it has become clear that the two lines 
of research should be investigated together in order to fully understand the implications of 
dysfunctions in either one.  
Also, it has to be stated that no studies have been done researching the possible changes in 
emotion processing over the course of the disorder.  
1.3.5. Working memory 
A basic definition of working memory describes it as online maintenance and manipulation of 
information. This information may not be directly available in the current environment, but 
may also have been retrieved from long term memory. Working memory therefore refers to a 
broader class of memory phenomena which involve the maintenance and manipulation of 
active representations, without respect to their source.  
Alan Baddeley and Graham Hitch have been considered the founders of working memory 
theory. In 1974, they hypothesized a working memory model which consists of three 
operating systems, two specialized subsystems devoted to the presentation of information of a 
particular type, meaning the visuo-spatial sketchpad for visual info and the phonological loop 
for any kind of verbal information. Those two subsystems are independent from each other. 
They are also called “slave systems”, and are controlled by a central executive system, which 
would coordinate the two subsystems. However, all three systems have limited capacity, 
which means only a finite amount of information is directly available for processing in 
memory. Information coming into the working memory systems is first analysed by 
perceptual modules and then transferred into specialized storage buffers. These buffers have 
no other role but to temporarily hold pre-processed units of information. The pieces of 
information that reside in such buffers are subject to passive, time-based decay as well as 
interference by items stored in the same specialized buffer (A. D. Baddeley & Hitch, 1974). 
To prevent that, Baddeley introduced an articulatory control process (A. Baddeley & Salame, 
1986) in which the material can be rehearsed and so kept in the working memory storage. The 
same is claimed to be true for the visuospatial sketchpad. It is therefore necessary to 
distinguish two different processes, elicited by two different kinds of task. Maintenance tasks 
refer to the process of keeping information in mind in the absence of an external stimulus, 
which would correspond to the use of the slave systems in the working memory model. 
Manipulation on the other hand refers to the reorganization of the information being 
maintained, and corresponds to the central executive in the working memory model.  
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Maintenance tasks correspond to so-called “domain specific” theories, where the main 
difference between activated brain regions lays in the type of material being processed. 
According to the domain specific theory, the frontal cortex is the primary site of working 
memory processes and different regions within the frontal cortex process different types of 
information. The vlPFC is believed to be responsible for the maintenance of stimulus form 
(object information) whereas the dlPFC is responsible for the maintenance of stimulus 
location (spatial information) (Goldman-Rakic, 1998). The theory is based on 
electrophysiological recordings and is an extension of the object-spatial (“what” versus 
“where”) visual processing streams found in posterior regions (Mishkin, Ungerleider, & 
Macko, 1983).  
The process specific theory focuses on the different processes performed within working 
memory (Petrides, 1995) and corresponds to manipulation tasks. Here, the difference between 
vlPFC and dlPFC lies not in the type of material being maintained but in the type of processes 
operating on that material. The vlPFC supports processes that transfer, maintain and match 
information in working memory. The dlPFC supports more complex processes operating on 
information that is currently maintained in working memory, such as monitoring and higher 
level planning. 
This dissociation between process and stimulus domain could explain controversial findings 
about the constitution of working memory. The more processes are involved in a certain 
working memory task, the more brain regions are involved and the harder it is to extract 
information about the domains in activation patterns during neuroimaging methods (Fletcher 
& Henson, 2001; Gruber & von Cramon, 2003).  
1.3.6. The N-back paradigm 
The N-back task is a paradigm often used to research working memory processes. It combines 
both maintenance and manipulation processes. It requires the monitoring of a continuous 
sequence of stimuli, and is answered correctly when the current stimulus matches the stimulus 
n positions backwards in the sequence. For n>0, this task requires both maintenance of the 
last n stimuli in order and updating of these stimuli each time a new stimulus occurs. The 
value n is often viewed as proportional to the working memory load, the total demand placed 
on the maintenance and/or manipulation processes.  
Different types of information can be used in n-back tasks, which can be differentiated into 
verbal stimuli, such as letters and words, and into nonverbal stimuli, such as shapes, faces, 
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and pictures. A second division concerns the type of monitoring that is required during the n-
back task. This can be either the identity of the stimulus that has to be monitored (e.g., is this 
the same letter as the one presented n-back) or the location of the stimulus (e.g., is this letter 
in the same location as the one presented n-back) (Owen, McMillan, Laird, & Bullmore, 
2005). Different brain structures are hypothesized to parallel these distinctions.  
1.3.7. Working memory deficits in BD 
Cognitive deficits in BD are widely studied, and there are some studies studying working 
memory in BD. All studies reported here have healthy control groups. Adler et al. (2004) gave 
15 euthymic bipolar patients a number 2-back task and found that bipolar patients performed 
more poorly and increased activation in the frontopolar PFC, temporal cortex, basal ganglia, 
thalamus, and posterior parietal cortex. No reductions in activation were found. Lagopoulos et 
al (Lagopoulos, Ivanovski, & Malhi, 2007) investigated the encode, delay, and response 
components of working memory for 3 different load conditions in 10 euthymic bipolar 
patients and found attenuated patterns of activity in prefrontal brain regions, across all 
working memory components. Mann-Wrobel et al. (2011) ran a meta-analysis for 
neuropsychological functioning in euthymic BD, among others investigating working 
memory. They did find differences between healthy controls and euthymic patients in 8 
studies testing with a digit span forward test, and 7 studies testing with a digit span backward 
test. They conclude that generalized, rather than specific, cognitive impairment characterizes 
euthymic BD. Monks et al. (Monks et al., 2004) gave 12 euthymic patients a letter 2-back task 
and found that, while performances did not differ between bipolar patients and controls, 
patients showed reductions of activation in bilateral frontal, temporal and parietal activation, 
and increased activation in the left precentral, right medial frontal and left supramarginal gyri. 
Thermenos et al. (2010) studied 19 euthymic bipolar patients, 18 healthy relatives of bipolar 
patients, and controls performing a 2-back working memory test and found that both relatives 
and bipolar patients overactivated the left anterior insula. Relatives also overactivated the 
orbitofrontal cortex and the superior parietal cortex. Patients, however, did not activate the 
left frontopolar cortex, as did relatives and controls. The authors conclude that the activity in 
working memory circuits is affected by activity in emotion regulatory circuits. Schecklmann 
et al. (2011) investigated 14 depressed bipolar patients with a working memory task with 
near-infrared spectroscopy and found attenuated activation in the PFC in all working memory 
loads. Finally, Townsend et al. (2010) measured 13 manic patients, 14 depressed patients, 15 
euthymic patients and 14 controls with a 2-back task and found that performance did not 
differ between groups. However, patients in all three mood states showed significantly 
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attenuated neural activation in working memory circuits when compared to healthy controls. 
Taken together, previous research suggests that working memory paradigms find 
hypoactivation in the PFC, along with worse performance levels for acutely ill patients 
compared to controls. When patients are measured in a euthymic state, results are 
contradicting, with some finding remaining performance deficits and hypoactivation, while 
others report no deficits between euthymic patients and healthy controls and hyperactivation 
in working memory related brain areas.  
It is noteworthy that no studies have been conducted measuring the same patients across 
mood states, and that group sizes are small. Also, patients were not followed over the natural 
course of their disorder to find out in which way cognitive deficits, such as working memory 
deficits, change over time.  
1.3.8. Neurophysiological measures of the n-back paradigm 
1.3.8.1. Functional near-infrared spectroscopy 
The Method called functional Near-Infrared Spectroscopy (fNIRS) is based on two principles: 
the neurovascular coupling and the optical window (Strangman, Boas, & Sutton, 2002). 
Neuronal activity is coupled spatially and temporally with a change in the cerebral blood flow 
and differences in the oxygenation of the blood, a phenomenon called neurovascular coupling 
(Logothetis & Wandell, 2004). Due to the increased need for oxygen in active neuronal cells, 
the blood flow in active brain regions rises with a short temporal delay. However, the local 
rise in oxygenated blood (O2Hb) flow overcompensates the need for oxygen from the 
neurons, creating a hyper-perfusion with O2Hb (Buxton, Uludag, Dubowitz, & Liu, 2004). At 
the same time, deoxygenated blood (HHb) levels decrease. After a few seconds, the 
concentration changes of O2Hb and HHb reach a peak and return to their respective basal 
levels. This curve is part of the neurovascular coupling and is called the hemodynamic 
response (see also Figure 3). Hemodynamic responses can differ within a person, as well as 
between persons in their peak value as well as in their duration (Fox, Snyder, Zacks, & 
Raichle, 2006; Huppert, Hoge, Diamond, Franceschini, & Boas, 2006). Even the 
hemodynamic responses between O2Hb and HHb can differ, Huppert et al (2006) reported up 




Figure 3. Hemodynamic response of oxygenated and deoxygenated blood with their respective 
peaks between 6s and 8s after the need for oxygen has arisen within the neurons  
(Obrig & Villringer, 2003; Strangman, et al., 2002) 
The second principle is that of the optical window. It is necessary to know that O2Hb as well 
as HHb contain chromophores, which are responsible for their red color through absorption of 
light of a certain wavelength. Near-infrared light has a wavelength ranging between 650 and 
950nm. This wavelength is coupled with the ability to penetrate tissue without the ability to 
absorb light (Obrig & Villringer, 2003). Therefore the wavelength spectrum of near-infrared 
light is called the optical window. The chromophores of O2Hb and HHb have the highest 
absorption rate of all biological tissue in this spectrum, a characteristic that fNIRS is drawing 
on. 
 
Figure 4. Optical Window displaying the different absorption maxima for oxygenated and 
deoxygenated blood   




To measure the changes in blood oxygenation levels, optical diodes, called optodes, are 
placed on the head. The optodes are arranged in plastic space holders, called probe sets, which 
are then strapped to the head. Each pair of emitter and detectors constitutes a channel. The 
probe sets are placed on the head according to the electrode positions of the international 10-
20 system (Jasper, 1958), which allows for a rough estimation of the brain areas measured 
(Okamoto et al., 2004).  
Some of the optodes emit near-infrared light (emitters) others detect near-infrared light 
(detectors). The light penetrates scalp, skull, and spinal fluids and is mostly absorbed by the 
chromophores in O2Hb and HHb. However, the light does not penetrate farther than the outer 
cortex region (Ferrari, Mottola, & Quaresima, 2004; Y. Hoshi, 2007), and the spatial 
resolution is rather small. Light which is not absorbed is caught by the detector. Using a 
modification of the Lambert-Beer law (Obrig et al., 2000), the interrelation between a 
weakening of the intensity of the near-infrared light, the concentration of the chromophores, 
an extinction coefficient, the distance between optodes and the differential path-length-factor 
at a certain wavelength is calculated. The calculations are based on the assumption, that the 
diffusion of light in the tissue and the path length factor stay constant.  
1.3.8.2. fNIRS and working memory 
Several studies have been published researching working memory and working memory 
components with fNIRS. However, results are mixed, with studies showing increases in 
ventrolateral prefrontal cortex (vlPFC) and decreases in dlPFC (Koike et al., 2013), or the 
other way around (McKendrick, Ayaz, Olmstead, & Parasuraman, 2014). Others found 
increasing activation with increasing working memory load (Ehlis, Bähne, Jacob, Herrmann, 
& Fallgatter, 2008; Ito et al., 2011; Pu et al., 2012; Schecklmann et al., 2013; Schecklmann et 
al., 2010; Schreppel et al., 2008; Vermeij, van Beek, Olde Rikkert, Claassen, & Kessels, 
2012). One of the most influential studies was published by Hoshi et al. (2003), who found 
robust activation in vlPFC and dlPFC in an n-back task, which was influenced by the 
increasing load of that task. Our own workgroup repeatedly used the n-back task and always 
found robust activation of the PFC depending on working memory load (Kopf, Schecklmann, 
Hahn, Dresler, et al., 2011). 
1.3.8.3. fNIRS in BD 
In all, 7 studies have been performed using fNIRS to examine brain activation in bipolar 
patients. Results, however, are not clear. Kubota et al. (2009) tested bipolar patients in various 
mood states performing multiple cognitive tasks. They find increased activation of prefrontal 
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areas compared to controls. Kameyama et al. (2006) investigated 17 bipolar patients who 
were either euthymic or depressed during a verbal fluency (VFT) and a finger-tapping task. 
They found decreased activation in the early part of the VFT which increased significantly 
and then differed in the opposite direction from healthy controls in the late part of the VFT. 
Matsuo et al. (2004) investigated 9 euthymic patients during a VFT and found a significantly 
slower increase in activation in the bipolar group. Matsuo et al. (2007) used the same 
experimental setting with 14 euthymic patients but added a condition where the patients had 
to inhale carbon dioxide (CO2) but found no differences between patients and controls in the 
added condition. The study by Schecklmann et al. (2011) found attenuated brain activation in 
an n-back task in depressed bipolar patients. Matsubara et al. (2014) had 16 remitted bipolar 
patients perform an emotional Stroop task and found that patients elicited heightened 
activation while reading threatening words. While viewing happy words, the activation in 
patients brains was decreased, and no differences between groups could be observed in the 
sad condition. Another paper by Takizawa et al. (2014) reports an effort to establish fNIRS 
activation during a verbal fluency task as a potential biomarker helping to distinguish between 
patient groups.  
Taken together, very little valid research exists studying bipolar patients with fNIRS, and the 
observations can be summarized as finding overall attenuated brain activation in bipolar 
patients with fNIRS. 
1.3.9. Event-related potentials 
Event-related potentials (ERPs) are defined as electrical voltage changes which manifest 
before, during or after a sensory, motoric or cognitive event in the electroencephalogram 
(EEG) (Schmidt & Birbaumer, 2005). An ERP therefore is the answer of the brain to an 
externally or internally produced stimulus, measurable as voltage curves. Amplitudes of ERPs 
are naturally very small, so that it is necessary to sum them up in order to make them stand 
out compared to background electrical activity of the brain.  
Positive and negative deflections of the ERP are called components. These components can 
be characterized by means of their polarity (positive or negative), their latency (in 
milliseconds, ms) or their amplitude (voltage in microvolt, µV). ERP components can be 
classified into exogenous and endogenous components. Exogenous components, also called 
primary answers, correlate to the early parts of a potential, and occur within the first 100ms 
after stimulus onset. They are modeled in their characteristics according to the physical 
properties of the stimulus (Olbrich, 1989), and are therefore viewed as correlations of primary 
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sensory processes. The endogenous components, or secondary answers, follow the primary 
sensory components and are less dependent on the physical properties of a stimulus. Instead, 
they are influenced by psychological factors, i.e. the salience of a stimulus (Olbrich, 1989). 
Therefore, endogenous components are considered as neuronal correlates of cognitive or 
emotional processes. The latency of a potential mirrors the temporal characteristics of the  
processing of a stimulus, its amplitude is interpreted as the intensity of the processing of that 
stimulus.  
1.3.9.1. ERPs and emotion 
The event related potential of this thesis is the late positive potential (LPP). The LPP  
constitutes a sustained positivity with a relatively late onset (circa 300 ms after the stimulus 
onset) and is proposed to be able to distinguish between the processing of emotional versus 
non-emotional stimuli. Compared to the non-emotional stimuli, the emotional stimuli have 
been shown to elicit a higher positivity in the EEG. The LPP has two components, an early 
and a late LPP, with the late LPP starting approximately 1000 ms after stimulus onset, 
whereas the early component starts around 300ms after stimulus onset and lasts until about 
600ms after stimulus onset. (Hajcak, Dunning, & Foti, 2009; Hajcak, MacNamara, & Olvet, 
2010). The LPP has developed from the P300, a 300ms after stimulus onset occurring positive 
potential, which has its maximum over parietal sites. The P300 is one of the most extensively 
studied ERPs (Polich, 2007). It has been used to study i.e. oddball effects, attention 
modulation, and working memory onset (Hajcak, et al., 2010; Olbrich, 1989).  Because of 
their intrinsic motivational significance, emotional stimuli might be considered natural targets 
for attention, and therefore soon the relevance of the P300 for emotional stimuli became 
apparent (Hajcak, et al., 2009). (Hajcak, et al., 2010). Today, the LPP is distinguished from 
the P300 in that it measures early emotional processing and late emotional regulation 
correlates.   
Studies have shown that the LPP is influenced by concurrent working memory tasks. It 
reduces the late positive potential. However, if test subjects have high anxiety, this effect is 
attenuated (MacNamara, Ferri, & Hajcak, 2011). 
The neurological correlate of the LPP remains unknown. Hajcak et al. (2010) argues that the 
LPP may index downstream processes resulting from increased activation of the amygdala, 
other researchers find complex networks to be correlated with the LPP, depending on the 
valence that needs to be processed (Liu, Huang, McGinnis-Deweese, Keil, & Ding, 2012). 
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1.3.9.2. The LPP in bipolar patients 
Up to now, no studies have been done researching the LPP in bipolar patients. This thesis will 
therefore be the first study on differences in the LPP in patients in their different mood states 
and compared to healthy controls. One study researched the LPP in MDD and found larger 
LPPs to higher arousing emotional pictures but no group differences for controls and subjects 
with a family history of MDD (Jaworska et al., 2012). 
1.4. Summary of previous research and hypotheses 
The theoretical background of the relevant research findings can be summarized as follows: 
BD is characterized by dysfunctional emotion processing and cognitive deficits, and it is not 
clear whether these deficits still remain in euthymia (1.2).  
Studies show abnormalities in the structure and function of key emotional control networks, 
as well as attenuated function in key cognitive brain areas leading to cognitive deficits (1.3).  
Many studies have been done researching cognitive deficits, and working memory in detail, 
and much more have reported emotional dysfunction. However, the interconnection between 
these two key domains has not been taken into account. Studies following patients over time 
and measuring their functionality in the above mentioned key components are sparse or non-
existing. The aim of this thesis is to capture the course of BD in patients over different mood 
states in regard to the two key components, cognitive function and emotional processing. A 
novel n-back paradigm containing both working memory components and emotional stimuli 
will be established, a pilot study will be done to show validity of the paradigm, and patients 
will be recruited in a) an acutely ill phase and b) later on during remission Patients’ 
performance will be measured by two neurophysiological measures, fNIRS and EEG, in order 
to capture both hypothesized dysfunctional components of the disorder. The hypotheses 




1. Working memory function: 
1.1. Patients show significantly worse performance during an acute phase, compared with 
healthy controls. Their brain activation will be attenuated compared to controls, and 
this attenuation will increase with increasing working memory load. 
Electrophysiological changes in the LPP will be different for patients and controls.  
1.2. Patients will perform on the same level as controls in remission. They will perform 
significantly better than in the ill phase. Brain activation, however, will still be 
attenuated compared to controls, and not different from their acute ill phase. LPP 
differences between patients and controls will not vanish.  
2. Emotion processing: 
2.1. Patients will show differences in emotional processing compared to controls. They 
will be slower to react to emotional stimuli and make more errors when compared to 
controls. Their brain activation will be attenuated for emotional stimuli, and their LPP 
will be heightened when compared with controls.  
2.2. Performance differences will vanish when patients return to their remitted state, and 
will not be different from controls anymore. However, brain activation and LPP 
Amplitude to emotional stimuli will remain different compared to controls. 
3. Interaction between working memory and emotion processing: 
3.1. The performance in the n-back task will be influenced by the emotional valence of the 
stimulus presented in the working memory task.  
3.2. This influence will change with increasing working memory load, and the influence 
will be different for patients compared to controls.  
3.3. This influence and the difference between patients and controls will remain when 




2.1. Study design 
At first, a preliminary study was conducted to test whether the paradigm was able to elicit 
different activation patterns for each condition tested with fNIRS, and establish these 
activation patterns as a baseline from which patients should differ. After analysis of the 
prestudy, the main study was conducted as a repeated measures design, with patients being 
measured in their acute ill phase while being inpatients in the university clinic. These patients 
were then asked to come back in a fully remitted state at least three months after release from 
the clinic, and were tested again. Control subjects, which were not identical to the subjects 
from the prestudy, chosen for their matching with the patients in age, sex, and educational 
degree, were tested once. Controls were not tested again because of monetary restrictions. It is 
also reasonable to believe that n-back tests are fairly reliable when retested (Hockey & 
Geffen, 2004). 
The study was reviewed and approved by the Ethics Committee of the University of 
Würzburg, and all procedures were in accordance with the latest version of the Declaration of 
Helsinki. All test subjects gave written informed consent after comprehensive explanation of 
the experimental procedures. 
2.2. Test Subjects 
2.2.1. Recruiting, inclusion and exclusion criteria 
One patient and four controls had to be excluded prior to data analysis after meeting the 
exclusion criteria.  
Test subjects were excluded if they had one of the following: previous history of stroke or 
traumatic brain injury, as well as previous operations on the head, epilepsy, and diseases 
influencing their systemic circulation, such as diabetes, to ensure equal interpretation of the 
fNIRS data. The age range of test subjects was 18-60 years.  
Control subjects had to be free of any past or current axis I disorders according to the DSM 
IV. They were screened with the Mini International Neuropsychiatric Interview (MINI), 
German version 5.0 (Sheehan et al., 1998). 
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Bipolar patients were recruited while being inpatients in a specialized bipolar ward at the 
university hospital psychiatric clinic. Their disorder status was diagnosed and confirmed by 2 
psychiatrists and extensive testing with the OPCRIT diagnostic system (McGuffin, Farmer, & 
Harvey, 1991).  Patients disorder status was recorded with the Montgomery Asberger 
Depression Rating Scale (MADRS) scores (Montgomery & Asberg, 1979) and Young Mania 
Rating Scale (YMRS) scores (Young, Biggs, Ziegler, & Meyer, 1978). 
Included were patients with bipolar I or bipolar II disorder. Patients receiving 
electroconvulsive therapy were excluded.  
Patients coming back at T2 had to be free of symptoms according to DSM IV criteria 
measured with MADRS and YMRS. Cut-off scores for depression were 9 points in the 
MADRS and 6 for Mania in the YMRS.  
2.2.2. Sociodemographics 
To compare state affect between groups, test subjects completed the Positive Affect Negative 
Affect Scale (PANAS) (Watson, Clark, & Tellegen, 1988) before taking part in the 
experiment. The PANAS comprises of 2 subscales, one measuring positive affect (PA) and 
one measuring negative affect (NA). The scale consists of 20 items, and each item is rated on 
a 5-point scale ranging from 1 = very slightly or not at all to 5 = extremely to indicate the 
extent to which the respondent has felt this way in the indicated time frame. High-NA 
characterizes subjective distress and unpleasurable engagement, and low NA stands for the 
absence of these feelings. By contrast, PA represents the extent to which an individual 
experiences pleasurable engagement with the environment. Thus, emotions such as 
enthusiasm and alertness are indicative of high PA, whilst lethargy and sadness characterize 
low PA (Crawford & Henry, 2004). Details on the PANAS and socio-demographic details can 








Table 1. Socio-demographic details and PANAS scores.  
SD indicates the standard deviation. 
 Pilot study Controls Patients ill 
Patients 
remitted 
Sex ♂/ ♀ 16/16 18/23 18/28 4/14 
Age (mean±SD) 23.6±2.7 39.7±10.8 41.4±11.3 39.6±10.9 
Educational degree 
(median) 
3 2 2 2 
MADRS (mean± SD) -  - 21.2±9.8 2±2.6 
YMRS (mean± SD) -  - 4.3±4.2 0.1±0.3 
PANAS PA (mean± SD)  -  29.9±5.4 24.6±7.5 26.2. ±4.2 
PANAS NA (mean± SD)  -  10.9±2.7 15.9±5.9 12.8±3.8 
 
The pilot study is not included in the following analyses since data is not compared later. 
Patients and controls did not differ in their sex (Chi²= .204, p= .65), their educational degree 
(U= 909, z= -.304, p= .76) or their age (t (84) = .78, p= .44). However, patients and controls 
did differ in their respective state affect. Detailed information as to the extent of this 
difference can be found in Table 2. The possible ramifications of these differences in state 
affect will be discussed in more detail in section 4 of this thesis.  
Table 2. Statistical evaluation of the PANAS scores.  
Significant differences are marked in bold. 
 
t df p value 
PANAS PA 
   mild depression vs. controls -2.49 52 .016 
depression vs. controls -5.32 60 .000 
manic vs. controls 1.13 47 .260 
mixed vs. controls -2.22 47 .031 
remitted vs. controls -1.04 58 .303 
acute vs. remitted -1.04 17 .312 
PANAS NA 
   mild depression vs. controls 4.63 52 .000 
depression vs. controls 5.09 60 .000 
manic vs. controls .82 47 .415 
mixed vs. controls 2.21 6.57 .065 
remitted vs. controls 1.91 58 .061 




2.2.3. Disorder status 
Since patients in all mood states were included in this study, it is necessary to make a 
distinction between different states. Since no clear cut-off scores are defined for the MADRS, 
a literature search has brought back the following scores which were used in this thesis as 
well: under 9 points: no depression; 9 – 23 points: mild depression; 23 - 35 points: depression, 
and over 35 points: severe depression. The same is true for the YMRS, so this study used the 
following cut-off scores: under 6: no mania; 6 – 12: hypomania; over 12: mania. And finally, 
patients who had mixed symptoms fitting both categories were labeled as mixed. Numericals 
of these categorizations can be found in Table 3. 
Table 3. Categorization of patients into subgroups according to their disorder status. 
mild depression 17 
depression 20 





Since there is still ongoing controversy about the impact of the property of the phase on brain 
activation, patients were splitted into 4 groups: a mild depression group, a depression group 
also containing the 2 severely depressed patients, a mania group with both manic and 
hypomanic patients, and a mixed group. The patients grouping can be seen in table Table 4. 
Table 4. Categorization of patients for subsequent analyses. 






Since this was a naturalistic study, all patients, both acutely ill and remitted, were medicated. 
A list of all medication data is attached in the supplement. There is much debate over the 
impact of medication on performance and brain activity. However, a new review by Hafeman 
et al (2012) summarized previous research and they concluded that, while medication seemed 
to influence structural MRI studies, it had only limited impact on functional MRI studies. The 
effects that were found pointed to a heightened blood flow in patients brains, making them 
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more similar to unmedicated healthy controls than their unmedicated counterparts. If any 
effects were found in blood oxygenation levels between patients and controls, this would 




Participants saw blocks of ten consecutive words presented on a computer screen (see also 
Figure 5). Two of these words were used as cues and were followed by a target word which 
was presented one, two or three words after the cue word, to vary the difficulty level and thus 
the working memory load. When the participants saw the target word, they were instructed to 
press the space key on a standard keyboard. Each block of ten words comprised one difficulty 
level. Also the emotional content of the words was varied; the words were positive, negative 
or neutral. Each block encompassed only one emotional valence. In total, there were three 
blocks where the emotional valence was negative and the difficulty level was one, meaning 
the target word followed the cue word directly. Three blocks had a negative emotional 
valence and the difficulty level was two, meaning there was one word between cue word and 
target word. Three blocks had a negative emotional valence and the difficulty level was three, 
meaning there were two words between the cue word and the target word. The same was true 
for the positive and the neutral emotional valence; therefore, in sum the experiment had 27 
blocks. Each block was 20 seconds long, and blocks were separated by a 20-second pause. 
Within each block, each word was visible for 500 ms, followed by a blank screen, which was 
also 500 ms long. The difficulty level of the blocks was pseudorandomized, and difficulty 
levels always varied from one block to another. In the pause preceding a block, the instruction 




Figure 5. Description of n-back task. 
Before the experiment, participants practised the task using one block of each difficulty 
(1, 2, 3-back). In each block they saw 30 consecutive neutral words in the 1-back condition, 
the same neutral words in the 2-back condition and in the 3-back condition.  
After the experiment, participants were prompted to evaluate the words used for their arousal 
and valence (words could be rated from 1: very unpleasant to 9: very pleasant and 1: not 
arousing to 9: very arousing). 
2.3.2. Word List 
The words (a list of which can be seen in Table 5) were chosen from the Berlin Affective 
Word List (Vo et al., 2009), were all nouns and matched for valence (positive nouns had a 
mean valence of 2, negative nouns a mean valence of -2 and neutral words a mean valence 
rating of 0, with the valence scale spanning from -3 for very negative to 3 for very positive). 
Mean arousal of emotional words was matched in respect of their valence, meaning the 
negative and positive words had a mean arousal of 3, the neutral words had a mean arousal of 
0 (on a scale from 1: very low arousal to 5: very high arousal). To ensure equal working 
memory load for all words, phoneme length (5), syllable length (2), and number of letters (6) 




Table 5. List of words used in the n-back paradigm.  
English expressions are found in the brackets. 
negative words positive words neutral words 
TYPHUS (typhus) RETTER (savior) ABLAUF (sequence) 
BEFEHL (order) WISSEN (knowledge) AFFEKT (affect) 
ARREST (warrant) MUTTER (mother) BANNER (banner) 
TYRANN (tyrant) GEWINN (win) GERUCH (smell) 
GREUEL (horror) GEFÜHL (feeling) KELLER (basement) 
SEENOT (distress at sea) HIMMEL (heaven) LOSUNG (watchword) 
HORROR (horror) FRIEDE (peace) STELLE (position) 
TRAUMA (trauma) URLAUB (vacation) ZEUGIN (eye witness) 
TERROR (terror) SOMMER (summer) AKZENT (accent) 
UNHEIL (calamity) FREUND (friend) INHALT (content) 
 
2.4. Electrophysiological measurements 
2.4.1. Functional Near-Infrared Spectroscopy 
An ETG-4000 Optical Topography system (Hitachi Medical Co., Japan) was used, with a 52-
channel array of optodes covering an area of 30 x 6cm of the forehead. The interoptode 
distance is 3 cm, in order to allow sufficient penetration depth. The array comprises of 17 
light emitters (semiconductor laser) and 16 photo-detectors (Avalanche photodiodes).The 
photo-detectors collect the reflected near-infrared light of its surrounding emitters. A channel 
is defined as the measuring point of activation, which is the region between one emitter and 
one detector. The array was fastened to the head by elastic straps. The probe set was placed on 
the head so that detector optode 26 was on the position for Fpz and aligned to T3/T4 (for 
emitter optodes 28 and 23), according to the international 10-20 system for EEG electrode 
placement (Okamoto & Dan, 2005). The array therefore covers both left and right frontal 
cortex areas. 
2.4.2. Electroencephalogram 
Continuous EEG was recorded from 5 scalp electrodes placed according to the 10/20 system 
(Jasper, 1958): Cz, CPz, Pz, CP1, CP2, and both mastoids. The ground electrode was placed 
on the left part of the scalp in the centroparietal region (corresponding to CP3). The 
electrooculogram (EOG) was recorded from four facial electrodes: vertical eye movements 
were measured with two electrodes placed approximately 1 cm above and below the right eye. 
Horizontal eye movements were measured using two electrodes placed 1 cm away from the 
outer canthi of each eye. ERPs were recorded with a 64-channel Quick Amp amplifier (Brain 
32 
 
Products, Munich, Germany) and Vision Recorder software (version 2.0, Brain Products, 
Munich, Germany). Data were referenced online to an average reference including all 
electrodes. This average referencing is a built-in feature of the Quick Amp and cannot be 
changed. However, due to the small number of electrodes, the data were rereferenced offline, 
for details please see the data analysis section. Sampling rate was set to 1000 Hz. All channels 
were amplified with a band-pass from DC to 200 Hz. The impedances were kept below 5 kΩ. 
2.5. Data Analysis 
The program SPSS, version 21 (IBM Corp. Released 2011. IBM SPSS Statistics for 
Windows, Version 21.0. Armonk, NY: IBM Corp.), was used for all statistical analyses. 
Details on the statistical tests used can be found in each subsection.  
2.5.1. Behavioral Data 
3x3 repeated measures analyses of variance (ANOVA) for the difficulty-levels (1-back, 2-
back and 3-back) by emotional valence (negative, positive and neutral) were conducted for 
the reaction time and the errors made in the experiment. In case of non-sphericity, 
Greenhouse-Geisser adjustment was used. This is true for all data analyses. Respective post 
hoc t-tests were conducted to evaluate differences between groups.  
2.5.2. fNIRS Data 
First, the high frequency portion of the signal was removed by applying a moving average 
(MA) filter with a time window of 1 s. To remove slow drifts, a 3 element discrete cosine 
transform basis set was then used on the data.  
The last five seconds before a block was taken as baseline period. Thereafter, the last 15 
seconds of the 20-second block were defined as the activation period, since 5 seconds after 
the initial trigger the neural response should already be seen in an increase in activation 
(Logothetis & Wandell, 2004). The mean of oxygenated haemoglobin [O2Hb] and 
deoxygenated haemoglobin [HHb] concentrations were computed for each segment and 
baseline-corrected. Since HHb concentrations did not reveal any new insights into the data, 
HHb will not be analyzed and discussed further. 
We assigned fNIRS channels to specific brain areas according to probabilistic maps (Tsuzuki 
et al., 2007) and defined regions of interest (ROIs) for both hemispheres. Based on previous 
work (Kopf, Schecklmann, Hahn, Dresler, et al., 2011; Owen, et al., 2005; Martin 
Schecklmann, et al., 2010), we defined the dlPFC (Brodman areas 9/10/46) as ROIs. This 
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corresponds to channels 3, 4, 13, 14, 15, 24, 25, 35, 36, 46 for the right dlPFC, and channels 
7, 8, 17, 18, 19, 28, 29, 38, 39, 49 for the left dlPFC. For statistical analyses of the fNIRS 
data, 3x3 ANOVAs for each ROI were calculated; the within-factors were load (i.e. 1-back, 2-
back and 3-back) and emotional valence (i.e. negative, neutral and positive). Subsequently, 
relevant post hoc tests were conducted. For details on channel placement and ROI location, 
see Figure 6. 
 
Figure 6. Channel placement on the brain.  
Numbers indicate separate channels of the NIRS measurement selected for ROI analyses. 
 
2.5.3. EEG Data 
The data were analyzed using Vision Analyzer 2 software (Brain Vision, Munich). Offline, 
the data were filtered with a Butterworth Zero Phase Filter with a low cut-off of 0.1 Hz and a 
high cut-off of 20 Hz, eye blink and ocular corrections were conducted according to the 
Gratton, Coles and Donchin (Gratton, Coles, & Donchin, 1983) algorithm.  
The data were then segmented into time windows starting 100 ms before the reference marker 
(indicated by the onset of a word) and ending 1900 ms after the reference marker.  
An automatic procedure built in the analyzer software detected and rejected artefacts: it was 
specified to reject any voltage steps more than 50.0 µV between sample points, a voltage 
difference of 300.0 µV within a trial, and a maximum voltage difference of less than 0.50 µV 
within 100 ms intervals. 
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After that, the data were re-referenced offline to a combined mastoid reference. Afterwards 
the baseline was corrected. The baseline, defined as 100 ms before word onset, was subtracted 
from the signal. 
Because the LPP is maximal at centro-parietal sites (Foti & Hajcak, 2008; Hajcak, Dunning, 
& Foti, 2007; Keil et al., 2002; Weinberg & Hajcak, 2010), it was scored as the average 
activity from five centro-parietal sites (Pz, CPz, Cz, CP1 and CP2). Based on this research 
and following our presentation time of the stimuli of 500 ms, we evaluated the window of 
350-600 ms after stimulus onset (mean activity). The late portion of the LPP was not analyzed 
because of the short time each word was visible. The target trials were too small in number 
and not analysed. In all, 24 trials of every condition went into the analysis.  
For the statistical analysis, the same ANOVA as for the fNIRS data was calculated. Relevant 





3.1. Pilot Study 
3.1.1. Valence and Arousal Ratings 
Repeated measures t-tests for the valence ratings showed significant differences for the 
valence between negative and neutral words (t (29) = 9, p < .001), between positive and 
neutral words (t (29) = 18.1, p < .001), and between positive and negative words 
(t (29) = 18.3, p < .001). Repeated measures t-tests for the arousal ratings showed significant 
differences for the arousal ratings between negative and neutral words (t (29) = 7.3, p < .001) 
and between the positive and neutral words (t (29) = 7.1, p < .001), but no significant 
differences between the positive and negative words (t (29) = 1.9, p > .05). The ratings 
completed by the participants were done in order to repeat the results from the original study 
by Vö et al (2009), and to ensure that the actual arousal and valence ratings were equal to the 
ones already published.  
3.1.2. Behavior 
A 3x3 repeated measures ANOVA revealed a significant main effect of the difficulty level on 
the reaction time (F (1.4, 58) = 31.3, p < .001). A main effect for the factor valence 
(F (2, 58) < 1) or interaction effect could not be found (F (4, 116) < 1). Post hoc t-tests for the 
main effect difficulty revealed significant differences, indicating increasing reaction times 
with increasing difficulty. All tests were significant (t (29) > 4.4, all p < .001). 
The tests for normal distribution in the error data showed significant p-values for all 
differences (all p < .001). Non-parametric Wilcoxon tests however, show the same results as 
parametric t-tests for paired samples (see also Table 6). Because we were interested in 
interaction terms, and the ANOVA is robust against violations of assumptions for parametric 
testing for N > 20 we therefore calculated a 3x3 ANOVA. Results from that ANOVA should 
be interpreted carefully. The 3x3 ANOVA for the errors revealed a significant main effect for 
the difficulty level (F (1.5, 43.9) = 15.6, p < .001). No significant main effect for the valence 
could be found (F < 1). A significant interaction effect for the errors (F (2.8, 82.1) = 3.7, p = 
.016) was observed, indicating that word valence influenced the error rate differentially in 
each difficulty level, the more difficult the task; the more errors were made especially in the 
negative valence condition. The details of the post hoc t-tests concerning the changes within 
the difficulty level are presented in Table 6. 
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Table 6.Non-parametric Wilcoxon and parametric t-test results for errors made.  
Significant differences are highlighted in bold. Marginally significant differences are written in 
italics. 
Errors t-tests Wilcoxon 
Load T df p value Z Sig. 
1-back         
Negative vs. Positive -1.438 29 .161 -1 .317 
Negative vs. Neutral -.571 29 .572 0 1.000 
Positive vs. Neutral -1.000 29 .325 -1 .317 
2-back          
Negative vs. Positive .215 29 .831 0 1.000 
Negative vs. Neutral 2.058 29 .048 -1.705 .088 
Positive vs. Neutral 1.428 29 .163 -1.429 .153 
3-back          
Negative vs. Positive -1.030 29 .311 -1.035 .301 
Negative vs. Neutral -3.695 29 .001 -2.977 .003 
Positive vs. Neutral 1.869 29 .071 -1.642 .101 
Valence      
Negative      
1-back vs. 2-back -1.139 29 .263 -1.342 .180 
1-back vs. 3-back -4.342 29 .000 -3.397 .001 
2-back vs. 3-back -3.840 29 .001 -3.132 .002 
Positive          
1-back vs. 2-back -1.438 29 .161 -1.633 .102 
1-back vs. 3-back -3.483 29 .002 -2.85 .004 
2-back vs. 3-back -2.175 29 .037 -1.877 .060 
Neutral          
1-back vs. 2-back -3.091 29 .004 -2.484 .013 
1-back vs. 3-back -2.490 29 .018 -2.309 .021 
2-back vs. 3-back 1.184 29 .245 -0.54 .589 
      
3.1.3. fNIRS 
3.1.3.1. Oxygenated Hemoglobin 
Four test subjects had to be excluded due to technical artefacts, so all analyses were based on 
26 test subjects. The 3x3 ANOVA for the oxygenated haemoglobin revealed a significant 
main effect for the difficulty level (F (2, 50) = 4.2, p = .021), no main effect for emotional 
valence (F (2, 50) = 1.2, p = .3), but a significant interaction effect (F (4, 100) = 2.6, p = .039) 
indicating that the word valence influences the oxygenation in a given difficulty level 
differentially (  
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Table 7 and Figure 7). A repeated measures ANOVA with the additional factor hemisphere 
revealed no differences in activation between the two hemispheres (F < 1). 
 
Figure 7. Changes in the oxygenated blood concentration in the ROI.  





Table 7. Post hoc t-tests for the ROI in the oxygenated condition.  
Consistent of BA9, BA10, BA46. Significant channels are highlighted in bold. 
Oxyenated hemoglobin changes   
Negative T df p value 
1-back vs. 2-back .835 25 .412 
1-back vs. 3-back -.050 25 .961 
2-back vs. 3-back -1.233 25 .229 
Positive       
1-back vs. 2-back -1.188 25 .246 
1-back vs. 3-back -2.838 25 .009 
2-back vs. 3-back -1.813 25 .082 
Neutral       
1-back vs. 2-back -2.382 25 .025 
1-back vs. 3-back -2.305 25 .030 
2-back vs. 3-back .239 25 .813 
1-back       
Negative vs. Positive 1.251 25 .222 
Negative vs. Neutral 2.710 25 .012 
Positive vs. Neutral .887 25 .383 
2-back       
Negative vs. Positive -.847 25 .405 
Negative vs. Neutral -1.895 25 .070 
Positive vs. Neutral -.561 25 .580 
3-back       
Negative vs. Positive -1.870 25 .073 
Negative vs. Neutral -.166 25 .869 
Positive vs. Neutral 1.926 25 .066 
 
3.1.3.2. Deoxygenated Hemoglobin 
The 3x3 ANOVA for the deoxygenated haemoglobin replicated the pattern described above. 
Again, there was a significant main effect for the difficulty level (F (2, 50) = 14.5, p < .001), 
no significant main effect for the emotional valence (F < 1) and a significant interaction effect 
(F (4, 100) =7.3, p < .001) (Table 8 and Figure 8). Again, the repeated measures ANOVA for 
the right and left hemisphere revealed no differences in activation between the two 




Table 8. Post hoc t-tests for the ROI in the deoxygenated condition.  
Significant channels are highlighted in bold. 
Deoxygenated hemoglobin changes 
Negative T df p value 
1-back vs. 2-back 1.652 25 .111 
1-back vs. 3-back 1.563 25 .131 
2-back vs. 3-back -.037 25 .971 
Positive       
1-back vs. 2-back 1.934 25 .065 
1-back vs. 3-back 4.716 25 .000 
2-back vs. 3-back 3.749 25 .001 
Neutral       
1-back vs. 2-back 4.632 25 .000 
1-back vs. 3-back 2.558 25 .017 
2-back vs. 3-back -1.960 25 .061 
1-back       
Negative vs. Positive -1.223 25 .233 
Negative vs. Neutral -2.055 25 .050 
Positive vs. Neutral -.748 25 .462 
2-back       
Negative vs. Positive -1.403 25 .173 
Negative vs. Neutral 1.742 25 .094 
Positive vs. Neutral 2.553 25 .017 
3-back       
Negative vs. Positive 2.625 25 .015 
Negative vs. Neutral -.722 25 .477 





Figure 8. Changes in the deoxygenated blood concentration in the region of interest.  





































The 3x3 ANOVA revealed a significant main effect for the difficulty level (F (2, 58) = 6.9, p 
= 0.002), a significant main effect for the emotional valence (F (2, 58) =5.4, p = .007) and a 
significant interaction effect (F (4, 116) = 2.7, p = .036). This indicates that the difficulty level 
of the working memory task modulates the response to emotionally salient words. Results 
from the post hoc t-tests can be seen in Table 9, and are also illustrated in Figure 9, and show 
that in the 1-back task, the LPP is not different between the emotional valence of the words, 
whereas in the 2-back task, the LPP differentiates between neutral and emotional words but 
not between the emotional valences. Finally, in the 3-back task it is only possible to dissociate 
the negative valence within the LPP. 
 
Figure 9. Stimulus locked ERPs averaged at Cz, Pz, CPz, CP1 and CP2 for the valences neutral, 





Table 9. Post-hoc t-tests for the LPP in the different conditions. 
Significant differences are highlighted in bold. 
EEG Data    
1-back T df p value 
Negative vs. Positive 1.218 29 .233 
Negative vs. Neutral -0.52 29 .604 
Positive vs. Neutral 0.836 29 .41 
2-back       
Negative vs. Positive -0.38 29 .709 
Negative vs. Neutral 3.567 29 .001 
Positive vs. Neutral 2.537 29 .017 
3-back       
Negative vs. Positive -1.58 29 .125 
Negative vs. Neutral 2.651 29 .013 
Positive vs. Neutral 0.643 29 .526 
negative       
1-back vs. 2-back -.316 29 .755 
1-back vs. 3-back 2.447 29 .021 
2-back vs. 3-back 3.314 29 .002 
Positive       
1-back vs. 2-back -1.811 29 .081 
1-back vs. 3-back .539 29 .594 
2-back vs. 3-back 2.872 29 .008 
Neutral       
1-back vs. 2-back 1.514 29 .141 
1-back vs. 3-back 2.765 29 .010 





3.2. Main Study 
3.2.1. Valence and Arousal Ratings 
3.2.1.1. Acutely ill patients versus controls 
To assess group differences for valence and arousal ratings, two 3x5 ANOVAs were 
calculated for valence ratings and arousal ratings with the between subject factor disorder 
status. 
For the valence, the ANOVA revealed a significant main effect for valence 
(F(1.4,119.1)=463.3, p<.001) and a significant main effect for subgroup (F(4,86)=2.6, p=.04). 
Post hoc t-tests were conducted for each group, differences can be seen in Figure 10. 
 
Figure 10. Valence Ratings for patient groups and controls.  
Lines above the bars indicate significant differences for the mild depressive group (N=12), the 
depressive group (N=20), the manic group (N=7), the mixed group (N=7) and the healthy 
controls (N=45). 
Group differences seem to be carried by manic patients who rate positive and neutral words 
more positive and mixed patients who rate neutral words more negative compared to the other 
groups.  
For the arousal, the ANOVA revealed a significant main effect for arousal 


















different from the arousal ratings for the positive words (t(85)=6.7, p<.001) and from the 
neutral words (t(85)=17.9, p<.001). Positive words were rated as significantly higher arousing 
than neutral words (t(85)=8.2, p<.001). No between group effects were detected.  
3.2.1.2. Remitted patients versus controls 
The same ANOVAs were also calculated for remitted patients versus controls. For the valence 
ratings, a main effect of valence was found (F(1.4,76.3)=540.9, p<.001). No group differences 
were detected.  
For the arousal ratings, the ANOVA revealed a main effect for arousal 
(F(1.7,95.6)=65.9, p<.001) and a main effect for group (F(1,55)=12.1, p=.001). Post hoc t-
tests showed that patients always rated words more arousing than controls 
(t(55)=2.5, p=.016 for positive arousal), (t(25.9)=3.2, p=.004 for neutral words) and 
(t(45.7)=2.9, p=.005 for negative words). 
3.2.1.3. Acutely ill patients versus remitted patients 
The 3x2 repeated measures ANOVA for valence revealed a main effect of valence 
(F(2,32)=406.1, p=<.001). No other effects were significant. Patients did not change their 
ratings over the course of the disorder.  
The 3x2 repeated measures ANOVA for arousal revealed a main effect of arousal 
(F(2,32)=45.7, p<.001). Patients did not change their arousal ratings over time.  
3.2.2. Behavior 
3.2.2.1. Acutely ill patients versus controls 
3.2.2.1.1. Reaction time 
A repeated measures 3x3x5 ANOVA was calculated for the factors load and valence, with the 
between factor disorder status, and detected a significant main effect for the factor load 
(F(1.8,164)=65.9, p<.001) and for the factor disorder status (F(4,82)=3.9, p=.005), as well as 
an interaction effect for valence*load (F(3.2,328)=4.9, p=.002). Reaction to 1-back words 
were fastest, followed by 2-back and reaction to 3-back words took the longest, and this was 
true for all groups.  
To further analyse group differences, groups were analysed separately.  
A 3x3x2 ANOVA for mildly depressed and control subjects revealed a significant main effect 
for load (F(2,102)=77.4, p<.001), a significant main effect for disorder status 
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(F(1,51)=7.7, p=.008), a significant interaction effect for load*valence 
(F(4,204)=5.3, p<.001), a marginally significant interaction effect for valence*disorder status 
(F(2,12)=2.8, p=.064) a significant interaction effect for load*disorder status 
(F(2,102)=3.5, p=.033) and a significant interaction for load*valence*disorder status 
(F(4,204)=3.1, p=.014). Post hoc t-test results can be seen in Figure 11 and Table 10. 
 
Figure 11. Reaction times for mildly depressed patients and controls.  
Lines above the bars indicate significant differences. 
The 3x3x2 ANOVA for depressed patients and controls revealed a significant main effect for 
load (F(2,118)=57.4, p<.001) and a significant main effect for disorder status 
(F(1,59)=10.3, p=.002). Since there was no valence effect in this ANOVA, different loads 
were averaged over all valences and only loads were compared in the post hoc t-tests. Results 
for this can be seen in Figure 12 and  



































Figure 12. Reaction time differences for depressed and control groups for the load conditions 
only.  
Lines above the bars indicate significant differences. 
The 3x3x2 ANOVA for manic patients and controls revealed a significant main effect for load 
(F(2,92)=29.4, p<.001). No other effects were significant.  
The 3x3x2 ANOVA for mixed patients and controls revealed a significant main effect for 
load (F(2,92)=36.8, p<.001), a marginally significant main effect for valence 
(F(2,92)=2.5, p=.084), and a marginally significant interaction effect for valence*disorder 
status(F(2,92)=2.8, p=.068). Since there was no load effect in this ANOVA, different valences 
were averaged over all loads and only valences were compared in the post hoc t-tests. 



























Figure 13. Reaction times for mixed patients and controls in the valence condition.  
No post hoc t-tests were significant. 
Table 10. Post hoc t-tests for REACTION TIME differences between groups.  
Significant differences are indicated in bold. 
Reaction time t df p value 
mildly depressed versus controls 
   positive 
   1-back 1.59 51 0.119 
2-back 2.99 13.94 0.01 
3-back 2.09 13.74 0.056 
neutral 
   1-back 1.73 51 0.089 
2-back 2.92 51 0.005 
3-back 2.85 51 0.006 
negative 
   1-back 1.72 13.01 0.109 
2-back 1.38 51 0.175 
3-back 1.63 51 0.11 
depressed versus controls 
   1-back 3.24 59 0.002 
2-back 2.94 59 0.005 


























3.2.2.1.2. Omission Errors 
Since errors tend to be not normally distributed, a Kolmogorov-Smirnoff test for normal 
distribution was applied, but turned out non-significant, all errors made lay within a normal 
distribution. Afterwards, a 3x3x5 repeated measures ANOVA was calculated for factors load 
and valence and between factor disorder status. The main effect for load (F(1.4, 
164)=44.5 p<.001), the main effect disorder status (F(4,82)=2.9, p=.024) and the interaction 
effects load*valence (F(3.1,328)=3.6, p=.012) and load*subgroup (F(8,164)=2.2, p=.027) 
turned out significant. The interaction effect valence*subgroup was marginally significant 
(F(8,164)=1.9, p=.058). Patients made more errors than did controls, the number of  errors 
depending on their respective subgroup and the valence of the word. The amount of errors in 
a load condition was influenced by the valence of the presented words.  
To further analyse group differences, groups were analysed separately.  
A 3x3x2 ANOVA for the mildly depressed group and controls returned a significant main 
effect for load (F(1.7,88.4)=22.4, p<.001), a significant main effect for valence 
(F(2,102)=4.5, p=.013), and a significant interaction effect for load*valence 
(F(3,154.9)=2.9, p=.037). The main effect for disorder status was marginally significant 
(F(1,51)=2.8, p=.097). Patients made marginally more errors than controls. Since there were 
no significant interaction effect for disorder status and load or valence, both load and valence 
conditions were averaged and then compared between groups with independent t-tests, for 
results please see Figure 14 and Table 12. Patients did not differ from controls in the load 
condition in the post hoc t-tests. In the valence condition, patients made more errors when 




Figure 14. Omission errors for mildly depressed patients and controls for the valence condition. 
Only the neutral valence produced significant differences. 
A 3x3x2 ANOVA for the depressed group and controls revealed a significant main effect for 
load (F(1.5,88.9)=27.4, p<.001), a significant main effect for disorder status, a significant 
interaction effect for load*disorder status (F(1.5,88.9)=4.7, p=.02), and a significant 
interaction effect for load*valence (F(3.2,182.4)=3.6, p=.013). Since no significant effects 
arose for valence, valences were averaged and only load conditions were compared in the t-
tests, for results please see Figure 15 and Table 12. Depressed patients made more errors than 




























Figure 15. Omission errors for depressed patients and controls in the load conditions.  
Differences in 2-back and 3-back task were significant. 
A 3x3x2 ANOVA  for the manic patients and controls revealed significant differences for the 
main effect load (F(1.7,80.5)=36, p<.001), a significant main effect disorder status 
(F(1,46)=10.7, p=.002), a significant interaction effect for load*disorder status 
(F(1.7,80.5)=10.6, p<.001), and a significant interaction effect valence*disorder status 
(F(2,92)=6.1, p=.003). Results for independent post hoc t-tests can be seen in Figure 16 and 
Table 11. Patients made more errors than controls only in the positive and negative valence 
























Figure 16. Omission errors for manic patients and controls.  
Significant changes are indicated by lines above the bars. 
Table 11. Post hoc t-tests for manic patients versus controls for OMISSION ERRORS. 
Significant results are highlighted in bold. 
Omission errors t df p value 
Mania versus controls 
   positive 
   1-back 0.731 6.435 0.491 
2-back 3.137 46 0.003 
3-back 2.83 6.49 0.028 
neutral 
   1-back 1 6 0.356 
2-back -1.372 15.219 0.19 
3-back 1.331 6.69 0.227 
negative 
   1-back -2.619 40 0.012 
2-back 0.635 6.589 0.547 
3-back 2.715 46 0.009 
 
The 3x3x2 ANOVA for mixed patients and controls revealed a significant main effect for 
load (F(1.7,79.9)=21.3, p<.001), a significant main effect for disorder status 
(F(1,46)=7.7, p=.008), a significant interaction effect for load*valence 


























(F(1.7,79.9)=3.6, p=.037). With increasing load, mixed patients made more errors compared 
to the control group. Since no significant effects arose for valence, valences were averaged 
and only load conditions were compared in the t-tests, for results please see Figure 17 and 
Table 12. However, no post-hoc t-tests were significant.  
 
Figure 17. Omission errors for mixed patients and controls.  

























Table 12. Post hoc tests for OMISSION ERRORS for the factors load and valence for each 
patient group versus the control group.  
Significant results are highlighted in bold. Marginally significant results are written in italics. 
Group vs. Controls t df p value 
Load 
   1-back 
   mild depression .19 51 .844 
depression .70 22.555 .488 
mixed 1.15 6.766 .290 
2-back 
   mild depression .83 51 .409 
depression 2.09 59 .040 
mixed 1.48 46 .146 
3-back 
   mild depression 1.35 13.56 .198 
depression 2.06 21.22 .052 
mixed 1.54 6.36 .171 
Valence 
   positive 
   mild depression 1.22 51 .227 
neutral 
   mild depression 2.02 51 .049 
negative 
   mild depression .64 51 .524 
 
3.2.2.2. Remitted patients versus controls 
3.2.2.2.1. Reaction time 
A repeated measures 3x3x5 ANOVA was calculated for the factors load and valence, with the 
between factor disorder status, and detected a significant main effect for the factor load 
(F(2,114)=70.7, p<.001). No other main effects or interaction effects returned significant. For 
visualisation of the results, please see Figure 18 and Figure 19. Patients as well as controls 
reacted fastest to 1-back tasks, were slower on 2-back tasks and the slowest on 3-back tasks, 
irrespective of their emotional valence.  
3.2.2.2.2. Omission Errors 
A repeated measures 3x3x5 ANOVA was calculated for the factors load and valence, with the 
between factor disorder status, and detected a significant main effect for the factor load 
(F(2,114)=19.6, p<.001). No other main effects or interaction effects returned significant. 
Results are visualised in Figure 20 and Figure 21. Patients as well as controls made the least 
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errors in 1-back tasks, more so on 2-back tasks and the most on 3-back tasks, irrespective of 
their emotional valence.  
3.2.2.3. Acutely ill patients versus remitted patients 
3.2.2.3.1. Reaction time 
A repeated measures 3x3x5 ANOVA was calculated for the factors load and valence, with the 
between factor disorder status, and detected a significant main effect for the factor load 
(F(2,34)=20, p<.001). No other main effects or interaction effects returned significant. For 
results, please also see Figure 18 and Figure 19. Acute patients did not differ in their 
performance when they returned to a remitted state.  
 





























Figure 19. Reaction times for ill patients, the same patients remitted and controls for the valence 
condition. 
 
3.2.2.3.2. Omission Errors 
A repeated measures 3x3x5 ANOVA was calculated for the factors load and valence, with the 
between factor disorder status, and detected a significant main effect for the factor load 
(F(2,34)=18.6, p<.001). No other main effects or interaction effects returned significant. 
Results are visualised in Figure 20 and Figure 21. Acute patients did not differ in their 



























Figure 20. Omission errors for the load condition, comparing ill patients which came back in 
their remitted state and controls. 
 
 
















































3.2.2.4. Summary of behavioral results 
The statistical analyses of the behavior produced a solid effect of load, i.e. with increasing 
working memory load. Reaction times and errors increased as well, and this was true for 
acutely ill patients as well as remitted patients and controls.  
Reaction time differences between groups were mainly carried by mildly depressed patients, 
who were slower than controls in the neutral valence for all load conditions, in the positive 
load condition only in the 2-back and 3-back tasks, and did not differ at all from controls in 
the negative condition, no matter how high the working memory load.  
Depressed patients were always slower than controls in all three working memory loads, no 
matter the valence of the word. 
Manic patients did not differ at all from controls in their reaction times.  
Mixed patients differed from controls in the valence, the took less time than controls to react 
to positive and negative words, but took longer to react to neutral words.  
All patients made more errors than controls. Manic patients produced more errors than 
controls in respect to the valence of the word, they made the most errors in the negative 
valence condition, and also significantly more errors in the positive valence condition. All 
other patients did not differ from controls in respect to valence conditions.  
When patients returned to their healthy remitted state, they did not perform differently. 
However, no differences could be detected when remitted patients were compared to healthy 
controls, either.   
3.2.3. fNIRS 
3.2.3.1. Oxygenated Hemoglobin1 
3.2.3.1.1. Acutely ill patients versus controls 
A 3x3x5 repeated measures ANOVA for the dlPFC with between factors valence and load 
and within factor disorder status revealed significant main effect for load 
(F(2,166)=3.9, p=.021), a marginally significant main effect for subgroup 
                                                 
1
 Recent research has shown that oxygenated hemoglobin measures can be artefact prone (Kirilina et al., 2012), 
an observation that is not made in deoxygenated hemoglobin concentration measures. Deoxygenated hemoglobin 
concentration was analyzed for this study but did not show any differential activation patterns. Since it is still 
more common to report oxygenated blood flow changes, it was decided to not discuss deoxygenated blood flow 
changes further in order to keep the results as readable as possible.  
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(F(4,83)=2.3, p=.072), and a marginally significant main effect for the interaction effect 
valence*load (F(4,332)=2.1, p=.082). No other effects were significant. 
The same ANOVA for the vlPFC produced a significant main effect for load 
(F(2,166)=8.9, p<.001) and a significant interaction effect for valence*load 
(F4,332)=3.03, p=.021). No other effects were significant. 
Since there were no group differences in the vlPFC, this region was not further analysed. 
The 3x3x2 ANOVA for the mildly depressed patients and controls revealed only a significant 
main effect of disorder status (F(1,46)=7.6, p=.008), for results please see Figure 22. No other 
effects were significant. Mildly depressed patients always activated the dlPFC significantly 
less than controls.  
 
Figure 22. Mean activation for load and valence conditions for mildly depressed patients and 
controls. 
The 3x3x2 ANOVA for depressed patients and controls revealed only a significant main 
effect for disorder status (F(1,51)=6,1, p=.017). Depressed patients activated the dlPFC less 
than controls. However, as can be seen in Figure 23, activation differences between groups 


































Figure 23. Mean activation for depressed patients and controls for load and valence conditions. 
The 3x3x2 ANOVA for manic patients and controls revealed a marginally significant main 
effect for load (F(1.8,106)=2.9, p=.065). No other effects were significant. Manic patients do 
not differ from controls in their activation patterns. Numeric results indicate that manic 





































Figure 24. Mean activation for manic patients and controls for load and valence conditions. 
A 3x3x2 ANOVA for mixed patients and controls found a significant interaction effect for 
load*valence (F(4,184)=4.2, p=.003) and a significant interaction effect for 
load*valence*disorder status (F(4,184)=3.2, p=.014). Significant post hoc t-test results can be 
seen in Table 13 and Figure 25 and Figure 26. 
Table 13. Post hoc t-tests for dlPFC activation for mixed patients and controls.  
Significant results are highlighted in bold. 
mixed patients vs. Controls t df p value 
positive 
   1-back -0.206 46 0.837 
2-back -2.123 46 0.039 
3-back -1.135 46 0.262 
neutral 
   1-back -2.024 46 0.049 
2-back 0.721 46 0.475 
3-back 0.963 46 0.341 
negative 
   1-back -1.326 6.845 0.227 
2-back 0.747 46 0.459 




































Figure 25. Mean activation for mixed patients and controls in valence and load conditions. 
 
 




































































Since the interaction effect of valence*load was also significant in dlPFC as well as vlPFC 
analyses, all test subject were analysed together in an ANOVA with the within factors valence 
and load and no between factor. This seemed also plausible in light of the fact that differences 
between groups were rather small. For the dlPFC, results returned a significant main effect for 
load (F(2,174)=4.7, p=.01) and a significant interaction effect for valence*load 
(F(4,348)=2.5, p=.041). Positive and neutral words did not influence the increase of activation 
produced by the increase in working memory load, negative words, however, actually 
produced a decrease of activation when working memory load increased.  
For the vlPFC, the ANOVA returned only a significant main effect for the factor load 
(F(2,174)=9.6, p<.001).  
3.2.3.1.2. Remitted patients versus controls 
For the dlPFC, a 3x3x5 ANOVA with within factors load and valence and between factor 
disorder status revealed so significant results at all.  
For the vlPFC, that same ANOVA returned a significant main effect for load 
(F(1.7,112)=3.9, p=.029) and an interaction effect for valence*disorder status 
(F(2,56)=4.7, p=.01). This seems to be driven by the activation of patients to neutral stimuli, 
whenever they had to react to neutral words, their activation patterns decreased significantly 
when compared to controls.  
3.2.3.1.3. Acutely ill patients versus remitted patients 
For the dlPFC a 3x3x2 repeated measures ANOVA for within factors load, valence and 
disorder status was calculated and returned a significant main effect for the factor load 
(F(2,32)=3.3, p=.048). No other effects were significant.  





Figure 27. Mean activation for ill and remitted patients and controls for the load condition. 
 
 
































































3.2.3.2. Summary of fNIRS results 
The PFC was activated according to each load condition increasingly, and different emotional 
valences modulated this activation: positive and neutral words did not influence the increase 
of activation according to the increase in working memory load, however, negative words 
actually seemed to produce a decrease in activation when working memory load increased. 
Activation differences between patients and controls were found mainly in mildly depressed 
patients, who activated the dlPFC less than controls, irrespective of the valence and load 
conditions. The depressed patients show a less pronounced difference in activation patterns. 
Manic patients show less activation to 1-back and 3-back working memory loads, and to 
positive and negative words. Mixed patients seem to always show less activation in the dlPFC 
than controls, however, activation patterns here are unclear.  
When remitted patients are compared to controls, differences in activation mainly 
disappeared, however, in the neutral valence condition, patients seem to activate less than 
controls. Differences between ill patients and the same patients in a remitted state could not 
be detected either.  
 
 
Figure 29. Manipulation check for the working memory condition.  
A depicts the 1-back, B the 2-back and C the 3-back activation. Depicted are significant changes 
in the t-values, all results are corrected for multiple testing with the DAP correction. 
 
3.2.4. EEG 
3.2.4.1. Acutely ill patients versus controls 
A 3x3x5 repeated measures ANOVA with between factors valence and load and within factor 
disorder status revealed significant main effect for load (F(2, 152)=23.9, p<.001), a significant 
main effect for valence (F(2,152)=6.6, p=.002),a significant interaction effect valence*load 
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(F(4,304)=4.9, p=.034), and a significant interaction effect valence*disorder status 
(F(8,152)=2.5, p=.012). No other effects were significant. 
A 3x3x2 ANOVA was calculated for the mildly depressed patients and controls, with within 
factors valence and load, and returned a significant main effect for valence 
(F(2,82)=7.5, p=.001) a significant main effect for load (F(1.6,67.2)=14.6, p<.001), a 
marginally significant effect for disorder status (F(1,41)=2.9, p=.092), a significant interaction 
effect for load*valence (F(4,164)=2.9, p=.021), and a significant interaction effect for 
valence*disorder  status (F(2,82)=3.8, p=.027). Post hoc t-tests for the valences averaged over 
all load conditions revealed a significant difference only for the negative valence, where 
mildly depressed patients had a higher LPP compared to controls.  
The 3x3x2 ANOVA for depressed patients and controls revealed a significant main effect for 
load (F(1.6,78)=16.3, p<.001), a marginally significant main effect for valence 
(F(2,94)=2.8, p=.066), and a significant interaction effect for load*valence 
(F(4,188)=2.9, p=.023). No other effects were significant. 
The 3x3x2 ANOVA for manic patients and controls revealed only a significant main effect 
for load (F(2,108)=12.5, p<.001). No other effects were significant.  
The 3x3x2 ANOVA for mixed patients and controls revealed significant main effects for load 
(F(2,84)=5.4, p=.006) and valence (F(2,84)=3.2, p=.044).  
Graphics of the LPP for all valences for all acutely ill patients and controls can be seen in 




Figure 30. LPP for negative pictures for acutely ill patients and controls. 
 




Figure 32. LPP for positive words for all ill patient groups and controls. 
 
3.2.4.2. Remitted patients versus controls 
The 3x3x2 repeated measures ANOVA produced a significant main effect for the factor load 
(F(2,104)=15.04, p<.001) a significant main effect for the factor disorder status 
(F(1,52)=5.09, p=.028) and a marginally significant interaction effect for load*valence 
(F(4,208)=2.2, p=.071). For details, please also see Figure 33, Figure 34 and Figure 35.  
3.2.4.3. Acutely ill patients versus remitted patients 
A 3x3x2 repeated measures ANOVA found a significant main effect for the factor load 
(F(2,32)=11.1, p<.001). No other effects were significant. For details, please also Figure 33, 




Figure 33. LPP changes in the 1-back load for ill and remitted patients and controls. 
 
 



































Figure 35. LPP changes in the 3-back condition for ill and remitted patients and controls. 
 
3.2.4.4. Summary of EEG data 
The factor load robustly influenced the LLP, leading to a decrease in the amplitude with 
increasing working memory load. Also, the valence of the word led to differences in the LPP, 
as negative words produced higher amplitude. Valence differences were influenced by the 
working memory load, the LPP for the negative valence decreased the least, and the most for 
positive valences. Only mildly depressed patients differed from controls. When patients were 




















4.1. Pilot study 
The first aim of this study was to investigate whether valence of words carefully matched for 
arousal has an effect on working memory performance. Error data revealed a modulation of 
performance by word valence. More errors were produced when the word had a negative 
valence, and that effect was most pronounced in the most difficult 3-back task. Reaction time 
did not resemble error data, as it increased only as a function of the increasing working 
memory load. It has been shown that reaction time in an emotional Stroop test was mainly 
influenced by arousal and not valence (Dresler, Meriau, Heekeren, & van der Meer, 2009). 
The words used in this study were selected based on their arousal similarities. This could be 
an explanation for the lack of reaction time effects. However, this would only apply to 
differences between the emotional conditions, but not to differences with neutral stimuli. 
Another explanation for this finding could be the small trial size, which may prevent finding 
significance when effects are small. 
The changes in the blood oxygenation level revealed a main effect of task difficulty and an 
interaction effect for difficulty by emotional valence. Even though the emotional word itself 
does not change the blood oxygenation as a mean of the valence, it seems to influence the 
brain activation nonetheless in such a way that the higher the load, the more pronounced the 
differences between the emotional valences. In detail, while the positive valence does not 
seem to have any effect on increases of oxygenated blood level, and the brain activation 
seems to be the comparable to a regular n-back task (Kopf, Schecklmann, Hahn, Dresler, et 
al., 2011; Martin Schecklmann, et al., 2010), the negative words seem to influence the 
activation levels so that no change between the different load conditions is detectable. The 
same pattern becomes even more pronounced in the deoxygenated blood flow changes. This 
effect of reduced blood flow changes in reaction to negatively valenced stimuli has also been 
shown by other groups (Perlstein, Elbert, & Stenger, 2002) with emotional pictures, who 
found reduced activation in the dlPFC for the negative pictures. However, the neutral words 
induce an unexpected pattern of activation changes, both in oxygenated and deoxygenated 
haemoglobin levels. From the 1-back to the 2-back condition they increase activation in a 
manner similar to the positive words. However, as the task becomes even more complicated, 
the neutral words seize to increase activation: in the 3-back task they cannot be differentiated 
from the negative words anymore. We expected the neutral words to elicit activation patterns 
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that show an increase in activation from 1-back to 2-back to 3-back, as can be seen in working 
memory tasks using letters (Kopf, Schecklmann, Hahn, Dieler, et al., 2011; Martin 
Schecklmann, et al., 2010).We have no explanation for the discrepant findings so far. We 
tested whether some participants might have had different evaluation criteria for the words, 
and aimed to identify outliers within the rating of the words, but the visual inspection could 
not account for the findings. It is also possible that the different arousal for the neutral words 
is causing part of the unexpected pattern, and together with the very low difficulty level of the 
task itself could provide an explanation. 
We next analyzed the LPP, and found significant effects of emotion, but also significant 
effects of difficulty or working memory load and a significant interaction between both. In the 
2-back task, the LPP distinguishes between neutral and emotional words very clearly, whereas 
in the 1-back task that distinction is not detected. In the 3-back task, the only distinction 
visible in the LPP is for the negative words. It seems that in the easier 2-back condition, the 
arousal of the word is important for the distinction the LPP can provide, whereas in the most 
difficult 3-back condition, valence is the key to distinction. We can therefore show that the 
LPP as well can be influenced by the difficulty level in a working memory task, and 
differentially for the different emotional valences (MacNamara, et al., 2011). However, 
contrary to earlier findings by MacNamara and colleagues, when using the stimulus itself as 
the carrier of the emotional valence, the LPP first becomes larger with increasing working 
memory load, and only when the load increases further, we observed a decrease in the LPP. 
That may be due to the different paradigms used, as the study by MacNamara and colleagues 
used emotional pictures, and they were only used as distractors, not as the stimuli to be 
remembered themselves, which were strings of letters. But nonetheless, the main finding of 
the LPP results in our study as well as in that of MacNamara et al. (2011) is that emotion 
processing is influenced by a simultaneously occurring working memory task, which 
takes away more and more capacity from emotion processing as the load increases.  
Taken together, our data suggest that it is not only arousal that plays a role in the modulation 
of working memory but also the valence of the emotional content stored in working memory 
may play a role in its function. This underlines and extends findings from Levens and Phelps 
(2008) who used a similar paradigm to show emotion effects on working memory, and 
furthermore points to the importance of the valence itself.  
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By integrating the two methods, we conclude that the emotional content of words is 
influencing working memory performance measured by prefrontal blood flow changes, and 
that working memory performance is influencing the processing of emotional stimuli. 
4.2. Main Study 
In order to discuss the main hypotheses, they are stated again at the beginning of this 
discussion. Afterwards, however, all hypotheses will be discussed for each patient group and 
the control group at once, to account for the study design, which was set up in order to 
analyse interactions between working memory and emotion processing.  
1. Working memory function: 
1.1. Patients show significantly worse performance in their acute ill state, compared with 
healthy controls. Their brain activation will be attenuated compared to controls, and 
this attenuation will increase with increasing working memory load. 
Electrophysiological changes in the LPP will be different for patients and controls.  
1.2. Patients will perform on the same level as controls in their remitted state. They will 
perform significantly better than in the ill phase. Brain activation, however, will still 
be attenuated compared to controls, and not different from their acute ill phase. LPP 
differences between patients and controls will not vanish.  
2. Emotion processing: 
2.1. Patients will show differences in emotional processing compared to controls. They 
will be slower to react to emotional stimuli and make more errors when compared to 
controls. Their brain activation will be attenuated for emotional stimuli, and their LPP 
will be heightened when compared with controls.  
2.2. Performance differences will vanish when patients return to their remitted state, and 
will not be different from controls anymore. However, brain activation and LPP 




3. Interaction between working memory and emotion processing: 
3.1. The performance in the n-back task will be influenced by the emotional valence of the 
stimulus presented in the working memory task.  
3.2. This influence will change with increasing working memory load, and the influence 
will be different for patients compared to controls.  
3.3. This influence and the difference between patients and controls will remain when 
patients are measured again in their remitted state.  
Patients indeed did perform worse than controls in their acute ill state. They were slower than 
controls, and they made more errors. However, the magnitude of the performance differences 
varied between patient groups.  
4.2.1. Depressed patients 
Depressed patients were overall slower and made more errors than controls, and that effect 
increased when the working memory load increased, just as expected. This was also prevalent 
in the brain activation measured with fNIRS. Patients activated their dlPFC significantly less 
than controls. Interestingly, this was not true for the 3-back condition as well as the negative 
word condition, where activations did not differ from controls. The underlying processes are 
not clear. Maybe patients did try hard to solve the working memory task, and even more so in 
the 3-back condition, even if that did not sum up to a better performance. The negative 
valence of a word could be processed with more priority than neutral and positive words, and 
therefore stimuli with a negative valence would be processed better than other stimuli.  
In the LPP, depressed patients did not differ from controls. Reasons for that could be 
numerous. Depressed patients initially take high doses of medication, and combinations of 
medication, such as selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, 
antipsychotic medication and lithium for mood stabilization. All these medications are 
hypothesized to have an influence on brain activation, even if the extent of that effect is 
unclear (Dodds et al., 2009; Frodl et al., 2011; Hafeman, et al., 2012; Loubinoux et al., 2005; 
Patin & Hurlemann, 2011). The medication effect could not be controlled for, since this was a 
naturalistic study and medication differed so much in dose and type between patients. This 
makes it very hard to find common variables with valid conclusiveness for all patients. 
Medication effects therefore can only be speculated about. It is quite possible that changes in 
brain activation and electrophysiology have an onset soon after initiation of the medication, 
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despite the fact that clinical measures including cognitive performance lag behind. The fact 
that patients report side effects, such as tiredness, dizziness, and changes in the saliva flow, 
right after taking the medication for a few times, underlines this theory. Catherine Harmer 
(2008) discussed in her review of serotonin and emotional processing that antidepressant 
effects can be seen as early as after the first intake of an SSRI with neuroimaging methods. 
She describes increased responses to negative facial expressions after the initial start of the 
pharmacotherapy, which later normalize, and these increased responses induce changes in the 
patients mood after a few weeks. Interestingly, this can also be seen in the mildly depressed 
sample discussed next.  
4.2.2. Mildly depressed patients 
In the group of patients who only showed mild depressive symptoms, performance and 
activation patterns changed. Patients took longer to react, but only when seeing positive or 
neutral words. When mildly depressed patients had to react to negative words, they did not 
differ from controls arguing for biased processing of these stimuli. Also, the increase of 
working memory load played a role. Differences manifested only in the higher load 
conditions. An emotional bias could also be seen for omission errors, where mildly depressed 
patients made more errors when seeing neutral words, and made the least errors when seeing 
negative words. Working memory performance however was not significantly different for 
mildly depressed patients and controls. The performance bias in negative stimuli is also 
reported in other studies (C.-H. Chen et al., 2006; Hulvershorn et al., 2012; Murphy et al., 
1999). Again, medication differed very much between patients, making it almost impossible 
to control for medication effects. 
In the fNIRS, mildly depressed patients showed the expected hypoactivations compared to 
controls. This hypoactivation has been described before (Martin Schecklmann, et al., 2011; 
Townsend, et al., 2010), and fits the current theory of cognitive deficits due to hypoactivation 
in the PFC in bipolar patients (Phillips, et al., 2003b). Interestingly, negative valence seemed 
to elicit the most activation in patients. Again, this has been found before in other studies (C.-
H. Chen, et al., 2006; Hulvershorn, et al., 2012). Harmer (2008) discussed this as well, 
reporting an increased processing of negative or aversive stimuli in the first weeks of 
treatment, this seems to be true  for this study also. 
This differential activation for valence could also be seen in the LPP, where mildly depressed 
patients showed a significantly higher LPP to negative words when compared to controls, but 
not to other valences, an effect which could not be seen in the load conditions, and therefore 
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did not point to an overall heightened LPP amplitude. It seemed that the initial anxiogenic 
effects of SSRI treatment (Harmer, 2008) induce a focus on negative valence, which seems to 
be processed with priority, as can be seen from the LPP. Stimuli with negative valence are 
processed sufficiently fast and correct in working memory, and elicit more brain activation.  
Taken together, working memory performance seen in depressed patients was poor and not 
influenced by the valence of a stimulus. They seem to mirror patients’ reported blunted affect, 
where lack of emotional resonance and response upon whatever emotional stimulus is a core 
symptom. The brain activation measured with fNIRS and EEG seems to be mainly influenced 
by the medication load. In contrast, patients who report less severe symptoms of depression 
show differential performance and activation pattern with a focus on negative stimuli, which 
is in line with patients’ reports of regaining their normal feelings and emotional tone, 
indicated e.g. by patients’ ability to cry or experience joy upon adequate experiences despite 
the ongoing negative, depressive cognitive distortions. The latter of which is also reflected by 
the preferential processing of negative words. Similar results are discussed by Harmer (2008). 
4.2.3. Manic patients 
When patients are manic, the picture looks different. They were as fast as controls when 
reacting to the words, but made the most errors of all patient groups. This fits the manic 
phenotype of heightened impulsivity, race of thought, distractibility, and reduced 
conscientiousness that also often results in impaired cognitive performance. Patients 
especially made more errors in the positive and negative valence conditions. It seems as 
though patients are more distracted by emotional stimuli. This has also been found before 
(Murphy, et al., 1999). 
The fNIRS results showed no significant effects for the manic patients when compared to 
controls. However, when looking at the data, manic patients clearly showed less brain 
activation for positive and negative words when compared to controls. The missing 
significance of this finding might be due to the small sample size (only 7 patients), which 
produced a high variance in the data. Even though, strictly taken, post hoc t-tests are invalid 
in this situation, explorative post hoc t-tests did show significant differences between patients 
and controls for positive and negative words. Other studies show differences in brain 
activation in manic patients compared to healthy controls, in working memory tasks as well as 
in tasks researching neural activation in emotion processing (Foland et al., 2008; Lembke & 
Ketter, 2002; Townsend, et al., 2010), so that the interpretation of our numeric data is in line 
with existing literature.  
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The same might be true for the LPP, where manic patients showed the smallest LPP 
amplitude of all patient groups in reaction to emotional words, however, no significant group 
differences arose. This indicates that, unlike it is the case for mildly depressed patients, the 
emotion processing deficits might be the main contributing factor to their acute ill state. 
Where mildly depressed patients were better when seeing negative words, and otherwise 
failed to perform as well as healthy controls, manic patients seemed to be so distracted by 
emotional valences. They could not process emotional stimuli sufficiently, as seen in the LPP, 
that they failed to perform like controls. It could seem as though emotional valence of the 
stimulus increased the overall processing of the stimulus, helping depressed patients to 
perform more like controls, whereas the same emotional valence distracted manic patients in 
such a way that they could not perform like healthy controls anymore. Interestingly, this has 
also been found before in a study by Foland et al. (2008), who found decreased PFC 
activation to be responsible for the problems in emotion activation.  
4.2.4. Mixed patients 
The results for mixed state patients compared to healthy controls are ambiguous. Mixed state 
patients were faster than controls in positive and negative conditions, in line with increased 
drive as usually present during mixed episodes, yet slower in the neutral condition. However, 
valence played no role in omission errors for these patients, as they only increased as a 
function of the working memory load, and they increased much more with increasing load 
when compared to controls. Their brain activation followed no pattern either. They showed 
attenuated brain activation compared with controls, however significant differences could 
only be found for the positive valence in the 2-back task, the neutral valence in the 1-back 
task and the negative valence in the 3-back task. For the LPP, they showed an overall increase 
in LPP, but no group differences arose. To add up all these findings, it almost seems as if 
mixed state patients showed neurophysiological features found in each of the different mood 
states: the heightened LPP from mildly depressed patients, and attenuated brain activation 
found in depressed patients, combined with pronounced abnormal emotion processing, which 
seems to be inefficient as can be seen in the overall high LPP. At the same time, they showed 
performance differences to differentially valenced stimuli, just like manic patients. When 
compared to the clinical phenotype of the patients, the data is reflected by their symptom 
presentation, where patients are anhedonic, show excessive rumination tendencies, but at the 
same time are anxious and agitated. It has to be taken into consideration that mixed patients 
are a very heterogeneous group of patients, whose mood state changes very quickly. 
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Taken together, the hypothesis that patients differ in their performance from controls was 
correct. This fits the existing research of cognitive deficits (Mann-Wrobel, et al., 2011). The 
hypothesis that patients show attenuated brain activation cannot be answered that easily. We 
find significantly reduced brain activation in mildly depressed and mixed patients, as well as 
numerically reduced brain activation in manic patients. The study by Townsend et al. 
(Townsend, et al., 2010) found attenuated brain activation in manic and depressed patients 
and therefore underlines our findings. However, severely depressed patients surprisingly 
differ. It seems crucial for future research to clearly classify the severity and direction of the 
mood episode before results can become comparable as episode polarity has a strong 
differential effect on all of the measures taken, including the LPP. The data on the latter 
cannot be related to other studies, as there are none. Considering the hypothesis that increased 
amygdala activation underlies increased LPP amplitudes (Hajcak, et al., 2010), then mixed 
patients should display the highest amygdala activation, as compared to manic patients, who 
show the least. This theoretical prediction is going to be tested in fMRI studies in our 
laboratory. Such an decreased amygdala reactivity might explain manic patients’ fearlessness, 
inappropriate risk assessment and high excitability to emotional stimuli: if the amygdala is 
hypo-activated, regulation processes cannot properly take place. This has been shown before 
by Foland et al. (2008) and Hulvershorn et al. (2012), who find abnormal amygdala activity in 
manic patients just as well.   
4.2.5. Remitted patients 
Some of the patients came back a second time in a remitted state to take part in the 
experiment again. Unfortunately, comparability with acutely ill patients is compromised: 
patients that did come back were in different mood states when they were measured the first 
time, so that no comparisons between all acute patients and all remitted patients can be made. 
Therefore, all comparisons with remitted patients will be only with themselves, and cannot be 
completely conclusive due to the fact that patients differ in their activation and performance 
patterns when they are in different mood states. In the following part, differences between 
remitted patients and controls will be discussed, as well as within-differences for patients who 
were measured in their ill state and again in their remitted state. 
Remitted patients did not differ from controls in their behavioral performance. However, 
remitted patients’ performance did not differ from their performance in the acute ill state 
either. The numerical data shows that indeed, patients did not improve in their performance 
when remitted, but, if anything, became worse. An explanation could be a selection bias, in 
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that patients who did come back for a second measurement were different as compared to the 
other patients in their acute ill state. Indeed, patients who did come back differed significantly 
in their MADRS scores, they had higher scores as compared to those who did not come back. 
The other explanation could well be that the small sample size of tested remitted patients 
produced a much higher variance in the data, which lead to non-significant results. This could 
also be true in light of the fact that patients did come from different acute ill states. This 
finding only highlights the importance of investigating the different phases of the disorder 
separately. However, the hypothesis that remitted patients do not show cognitive deficits 
anymore cannot be taken as proven, even if no significant differences arose from statistical 
analyses. An interesting side note is that more severe ill patients seem to be more inclined to 
take part in studies, presumably because they hope to improve their disorder state, whereas 
patients who completely remit do not see the need to take part a second time.  
For the fNIRS results, brain activation was not significantly different between remitted 
patients and controls, and not significantly different for acutely ill and remitted patients either. 
However, numerical data showed an increase in brain activation from ill to remitted to 
controls for the load condition, but not for the valence condition. When only researching 
working memory load, remitted patients showed a higher activation than in their acute ill 
phase, but they were not quite at the level of controls. In the valence condition, remitted 
patients only showed higher brain activation in the positive valence and the negative valence, 
whereas the neutral valence did not produce an improvement in brain activation at all for the 
patients over the course of their disorder. The same picture could be seen in the LPP. No 
significant results arose when comparing remitted patients to controls, as well as when 
comparing ill patients to their remitted state. However, when looking at the numerical data, 
the LPP amplitude overall was higher in ill patients than in controls, and increased even more 
in remitted patients, hinting at a differential emotion processing overall. It seems as though 
the direction of the LPP amplitude changes between valences and load conditions are the 
same, with the exception of the negative valence condition, which increases in controls, as 
well as in acutely ill patients and decreases in the remitted patients. The implications of these 
findings are unclear. (MacNamara, et al., 2011) found that working memory decreases the 
LPP but that this effect was attenuated by increasing anxiety. If emotional valence gets 
processed with more priority than in control subjects, the LPP does not decrease as much with 
increasing load. However, in this study, acutely ill patients behaved like controls, and 
remitted patients showed a decrease in the LPP amplitude for negative words in the 3-back 
condition, exactly the opposite of what was expected to happen, and what did happen in the ill 
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patients. Further studies of the LPP with more patients in a remitted state are needed in order 
to understand the effects of the disorder on the LPP. Possibly the LPP could function as an 
indicator for a trait of BD, as it is hypothesized to measure emotion processing.  
Taken together, the hypothesis that remitted patients return to a level of cognitive functioning 
where they cannot be distinguished anymore from healthy controls was not correct. While no 
statistical differences arose between remitted patients and controls, the same was true for the 
comparison between acutely ill and remitted patients, and the missing statistical difference 
between remitted patients and controls cannot be used to reject the null-hypothesis. Given the 
rather small sample sizes for these studies, power issues are most likely to account for these 
equivocal findings. The same is true for the hypothesis stating that brain activation remains 
attenuated. This could only be found for the neutral words, not for any other load or valence 
conditions. For the LPP, remitted patients showed an overall higher LPP amplitude than in 
their ill phase as well as compared to healthy controls. This might hint at a dysfunction of 
emotion processing in BD which does not decrease when patients are remitted. Recent 
research shows that subclinical symptoms in a remitted state are quite prevalent (Vieta, 
Sanchez-Moreno, Lahuerta, & Zaragoza, 2008). If one takes into consideration that patients 
with sub-threshold symptoms show attenuated cognitive functioning compared to completely 
remitted patients, and that our remitted patients were worse ill than the other patients who 
took part in the experiment, it might well be that this influenced performance and brain 
activation results.  
4.3. Conclusion  
If we take into account the proposed model of neurocircuit dysfunction in BD (Phillips, et al., 
2003b; Strakowski, et al., 2012), which consists of a hypoactive dorsal system, studied in this 
thesis using the working memory paradigm, and the overactive ventral system, tested in this 
thesis with LPP changes due to differently valenced words being shown, then the different 
disorder states could be interpreted in the following way: 
If the brain activation seen in the prefrontal cortex is part of an disturbed dorsal system in BD 
(Phillips, et al., 2003b; Strakowski, et al., 2012), then the predominantly disturbed system in 
both mildly and severely depressed patients could be the dorsal system, which show only 
small changes in the LPP, whereas the predominantly disturbed system in manic and mixed 
patients is the ventral system, which can be seen in hyperactivation of LPP-related neural 
correlates in mixed and hypoactivated neural correlates of the LPP in manic patients. When 
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patients are remitted, the dorsal system regains temporary stability, and can be compared to 
that of healthy controls, However the ventral system remains dysfunctional and causes the 
remaining performance deficits. If that is the case, performance deficits can be taken as state 
markers of the disorder, with pronounced deficits while patients are in an acutely ill phase,  
and emotion processing deficits could be a trait marker of the disorder, remaining even in full 
remission. Maybe subsyndromal BD patients would therefore profit from interventions 
aiming to stabilize the ventral emotion processing system. This would also explain that some 
patients show a clear manic polarity, and are systemically different from patients who show a 
clear depressed polarity, including the need for different medication (Popovic et al., 2012).  
The theory of the ventral emotion processing system being the one creating the remaining 
deficits should be researched further. Especially, the interconnectivity of the two systems 
needs to be implemented in paradigms researching both cognition and emotion, in order to 
find further proof of this theory. It would be important to study emotion processing deficits in 
patients over time, in an acutely ill phase as well as in remission. If the emotion processing 
deficits are indeed trait markers of the disorder, changes in the emotion processing system 
with changing manic and depressive episodes need to be researched further.  
Taken together, this study adds to the knowledge of deficits in working memory and emotion 
processing in BD. The emotional working memory paradigm established in the framework of 
the current thesis can be a reliable tool to research functional changes of the two core 
symptoms in BD over the course of the disease. It is important that patients are measured 
repetitively during acute phase and remission, in order to fully assess the extent of the 
cognitive and emotional changes in performance and brain activation. It is even more 
important that different mood states are studied separately, that medication is taken into 
account and that sufficiently powered samples are included in order to reliably find 
differences between groups and changes over time. The LPP needs to be analyzed further in 
order to establish the source of the potential and create the ability to conclude the underlying 





There are several limitations that should be kept in mind when interpreting the data. First, 
since this was a natural study setting, all patients were medicated, with medication varying in 
type (SSRI, venlafaxine, tricyclic antidepressants, antipsychotics, lithium and other mood 
stabilizers) and dose. Therefore, medication effects are expected, but cannot be controlled for. 
Some studies find medication effects on brain activation in working memory and emotion 
processing studies (Dodds, et al., 2009; Ertugrul et al., 2009; Frodl, et al., 2011; Pavuluri, 
Passarotti, Harral, & Sweeney, 2010). Especially, Patin and Hurlemann (2011) point to the 
effects of medication on amygdala function, and clearly state that more research is needed to 
understand the ramifications of different medication on amygdala activation. Hafeman et al. 
(2012) review bipolar medication effects in brain imaging studies and conclude that the 
picture is unclear. Phillips et al. (2008) conclude in their review that medication seems to take 
no effect on brain activation in bipolar patients. All significant results found in this study 
therefore have to be interpreted with special care as to the medication effects that possibly 
change brain activation. 
Second, no distinction was made between patients with bipolar I and bipolar II disorder. 
Numerous studies were conducted addressing possible cognitive differences between bipolar I 
and bipolar II patients (Ancin, Cabranes, Santos, Sanchez-Morla, & Barabash, 2013; 
Dittmann et al., 2008; Hsiao et al., 2009; Palsson et al., 2013), but the results are 
contradictory. A study by Summers et al. (2006) concerning cognition and emotion 
processing differences between bipolar I and bipolar II patients found that bipolar II patients 
are cognitively impaired more severely, but no differences between emotion processing tasks 
were found. They conclude that recurring depressive episodes have a more detrimental effect 
on cognition. While that fits well into our own data showing that the cognitive system seems 
to be more impaired in depressed patients, it also justifies the concern that our sample 
comprised both bipolar I and bipolar II disorder, and we did not distinguish between these 
patients to retain sufficient power.  
Third, the neural underpinnings of the LPP are essentially unknown. All interpretation of LPP 
data is therefore highly speculative. More research into the origins of this event related 
potential is needed in healthy controls, in order to be able to correctly interpret LPP findings 




Future research needs to address the interconnectivity of cognitive system and emotion 
processing system, to provide further evidence for a remaining dysfunctionality of the 
emotion processing system. While fNIRS is suitable for detecting cognitive deficits, the 
suitability of the LPP in order to better understand the underlying neural mechanisms is 
questionable. Maybe another ERP would be better suited to account for both cognitive and 
emotion processes. Functionality and interconnection of both systems could then function as 
an endophenotype for BD, which would help to identify genetic polymorphisms influencing 
both systems. This in turn would help improve treatment options for patients, with 
personalized medication for different polarities and different mood states, and improved 
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Table 1. ICD and DSM-IV criteria for BD. 
ICD 10 
F30 MANIC EPISODE 
F30.0 Hypomania 
A. The mood is elevated or irritable to a degree that is definitely abnormal for the individual concerned and  
sustained for at least four consecutive days.  
B. At least three of the following must be present, leading to some interference with personal functioning in  
daily living:  
(1) increased activity or physical restlessness;  
(2) increased talkativeness;  
(3) difficulty in concentration or distractibility;  
(4) decreased need for sleep;  
(5) increased sexual energy;  
(6) mild spending sprees, or other types of  
reckless or irresponsible behavior;  
(7) increased sociability or over-familiarity.  
C. The episode does not meet the criteria for mania  
(F30.1 and F30.2), bipolar affective disorder (F31.-), depressive episode (F32.-), cyclothymia (F34.0) or anorexia 
nervosa (F50.0).  
D. Most commonly used exclusion criteria: the episode is not attributable to psychoactive substance use (F1) or  
any organic mental disorder, in the sense of F0.  
F30.1 Mania without psychotic symptoms 
A. A mood which is predominantly elevated, expansive or irritable and definitely abnormal for the individual 
concerned. This mood change must be prominent and sustained for at least a week (unless it is severe enough to require 
hospital admission).  
B. At least three of the following must be present (four if the mood is merely irritable), leading to severe interference 
with personal functioning in daily living:  
(1) Increased activity or physical restlessness;  
(2) Increased talkativeness ('pressure of speech');  
(3) Flight of ideas or the subjective experience  
of thoughts racing;  
(4) Loss of normal social inhibitions resulting in  
behavior which is inappropriate to the  
circumstances;  
(5) Decreased need for sleep;  
(6) Inflated self-esteem or grandiosity;  
(7) Distractibility or constant changes in  
activity or plans;  
(8) Behavior which is foolhardy or reckless and whose risks the subject does not recognize e.g. spending 
96 
 
sprees, foolish enterprises, reckless driving;  
(9) Marked sexual energy or sexual  
indiscretions.  
C. The absence of hallucinations or delusions, although perceptual disorders may occur (e.g. subjective hyperacusis, 
appreciation of colors as specially vivid, etc.).  
D. Most commonly used exclusion criteria: the episode is not attributable to psychoactive substance use (F1) or any 
organic mental disorder, in the sense of F0.  
F30.2 Mania with psychotic symptoms 
A. The episode meets the criteria for mania without psychotic symptoms (F30.1) with exception of criterion C.  
B. The episode does not simultaneously meet the criteria for schizophrenia (F20) or schizo-affective disorder, manic 
type (F25.0).  
C. Delusions or hallucinations are present, other than those listed as typical schizophrenic in F20 G1.1b, c and d (i.e. 
delusions other than those that are completely impossible or culturally inappropriate and hallucinations, that are not in 
the third person or giving a running commentary). The commonest examples are those with grandiose, self-referential, 
erotic or persecutory content.  
D. Most commonly used exclusion criteria: the episode is not attributable to psychoactive substance use (F1) or any 
organic mental disorder, in the sense of F0.  
 
A fifth character may be used to specify whether the hallucinations or delusions are congruent or incongruent with the 
mood:  
F30.20 mania with mood congruent psychotic symptoms (such as grandiose delusions or voices telling the subject that 
he has superhuman powers)  
F30.21 mania with mood incongruent psychotic symptoms (such as voices speaking to the subject about affectively 
neutral topics, or delusions of reference or persecution).  
F30.8 Other manic episodes 
F30.9 Manic episode, unspecified 
F31 BIPOLAR AFFECTIVE DISORDER 
Note: Episodes are demarcated by a switch to an episode of opposite or mixed polarity or by a remission.  
F31.0 Bipolar affective disorder, current episode hypomanic 
A. The current episode meets the criteria for hypomania (F30.0).  
B. There has been at least one other affective episode in the past, meeting the criteria for hypomanic or manic episode 
(F30.-), depressive episode (F32.-) or mixed affective episode (F38.00). 
 F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms 
A. The current episode meets the criteria for mania without psychotic symptoms (F30.1).  
B. There has been at least one other affective episode in the past, meeting the criteria for hypomanic or manic episode 
(F30.-), depressive episode (F32.-) or mixed affective episode (F38.00).  
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms 
A. The current episode meets the criteria for mania with psychotic symptoms (F30.2).  
B. There has been at least one other affective episode in the past, meeting the criteria for hypomanic or manic episode 
(F30.-), depressive episode (F32.-) or mixed affective episode (F38.00).  
 
A fifth character may be used to specify whether the psychotic symptoms are congruent or incongruent with the mood:  
F31.20 with mood congruent psychotic symptoms  
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F31.21 with mood incongruent psychotic symptoms 
F31.3 Bipolar affective disorder, current episode moderate or mild depression 
A. The current episode meets the criteria for a depressive episode of either mild (F32.0) or moderate severity (F32.1).  
B. There has been at least one other affective episode in the past, meeting the criteria for hypomanic or manic episode 
(F30.-), or mixed affective episode (F38.00).  
 
A fifth character may be used to specify the presence of the somatic syndrome as defined in F32, in the current episode 
of depression:  
F31.30 without somatic syndrome  
F31.31 with somatic syndrome  
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms 
A. The current episode meets the criteria for a severe depressive episode without psychotic symptoms (F32.2).  
B. There has been at least one well authenticated hypomanic or manic episode (F30.-) or mixed affective episode 
(F38.00) in the past. 
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms 
A. The current episode meets the criteria for a severe depressive episode with psychotic symptoms (F32.3).  
B. There has been at least one well authenticated hypomanic or manic episode (F30.-) or mixed affective episode 
(F38.00) in the past.  
 
A fifth character may be used to specify whether the psychotic symptoms are congruent or incongruent with the mood.  
F31.50 with mood congruent psychotic symptoms  
F31.51 with mood incongruent psychotic symptoms  
F31.6 Bipolar affective disorder, current episode mixed 
A. The current episode is characterized by either a mixture or a rapid alternation (i.e. within a few hours) of 
hypomanic, manic and depressive symptoms.  
B. Both manic and depressive symptoms must be prominent most of the time during a period of at least two weeks.  
C. There has been at least one well authenticated hypomanic or manic episode (F30.-), depressive (F32.-) or mixed 
affective episode (F38.00) in the past.  
F31.7 Bipolar affective disorder, currently in remission 
A. The current state does not meet the criteria for depressive or manic episode in any severity, or for any other mood 
disorder in F3 (possibly because of treatment to reduce the risk of future episodes).  
B. There has been at least one well authenticated hypomanic or manic episode (F30.-) in the past and in addition at 
least one other affective episode (hypomanic or manic (F30.-), depressive (F32.-), or mixed (F38.00)).  
F31.8 Other bipolar affective disorders 
F31.9 Bipolar affective disorders, unspecified 
F32 Depressive episode 
 
G1. The depressive episode should last for at least 2 weeks.  
G2. There have been no hypomanic or manic symptoms sufficient to meet the criteria for hypomanic or manic  
episode (F30.-) at any time in the individual's life.  
G3. Most commonly used exclusion clause. The episode is not attributable to psychoactive substance use (F10- 




Some depressive symptoms are widely regarded as having special clinical significance and are here called "somatic". 
(Terms such as biological, vital, melancholic, or endogenomorphic are used for this syndrome in other classification.)  
 
A fifth character (as indicated in F31.3; F32.0 and F32.1; F33.0 and F33.1) may be used to specify the presence or  
absence of the somatic syndrome. To qualify for the somatic syndrome, four of the following symptoms should be 
present:  
(1) marked loss of interest or pleasure in  
activities that are normally pleasurable;  
(2) lack of emotional reactions to events or  
activities that normally produce an emotional  
response;  
(3) waking in the morning 2 hours or more  
before the usual time;  
(4) depression worse in the morning;  
(5) objective evidence of marked psychomotor  
retardation or agitation (remarked on or  
reported by other people);  
(6) marked loss of appetite;  
(7) weight loss (5% or more of body weight in  
the past month);  
(8) marked loss of libido.  
 
In The ICD-10 Classification of Mental and Behavioral Disorders: Clinical descriptions and diagnostic guidelines, the 
presence or absence of the somatic syndrome is not specified for severe depressive episode, since it is presumed to be 
present in most cases. For research purposes, however, it may be advisable to allow for the coding of the absence of the 
somatic syndrome in severe depressive episode.  
F32.0 Mild depressive episode 
A. The general criteria for depressive episode (F32) must be met.  
B. At least two of the following three symptoms must be present:  
(1) depressed mood to a degree that is definitely abnormal for the individual, present for most of the day and 
almost every day, largely uninfluenced by circumstances, and sustained for at least 2 weeks.  
(2) loss of interest or pleasure in activities that are normally pleasurable; (3) decreased energy or increased 
fatigability.  
C. An additional symptom or symptoms from the following list should be present, to give a total of at least  
four:  
(1) loss of confidence and self-esteem;  
(2) unreasonable feelings of self-reproach or  
excessive and inappropriate guilt;  
(3) recurrent thoughts of death or suicide, or  
any suicidal behavior;  
(4) complaints or evidence of diminished ability  
to think or concentrate, such as indecisiveness  
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or vacillation;  
(5) change in psychomotor activity, with  
agitation or retardation (either subjective or  
objective);  
(6) sleep disturbance of any type;  
(7) change in appetite (decrease or increase)  
with corresponding weight change).  
 
A fifth character may be used to specify the presence or absence of the "somatic syndrome" (defined on page xx):  
F32.00 Without somatic syndrome  
F32.01 With somatic syndrome  
F32.1 Moderate depressive episode 
A. The general criteria for depressive episode (F32) must be met.  
B. At least two of the three symptoms listed for F32.0, criterion B, must be present.  
C. Additional symptoms from F32.0, criterion C, must be present, to give a total of at least six.  
 
A fifth character may be used to specify the presence or absence of the "somatic syndrome" as defined on page xx: 
F32.10 Without somatic syndrome  
F32.11 With somatic syndrome  
F32.2 Severe depressive episode without psychotic symptoms 
Note: If important symptoms such as agitation or retardation are marked, the patient may be unwilling or unable to 
describe many symptoms in detail. An overall grading of severe episode may still be justified in such a case.  
 
A. The general criteria for depressive episode (F32) must be met.  
B. All three of the symptoms in criterion B, F32.0, must be present.  
C. Additional symptoms from F32.0, criterion C, must be present, to give a total of at least eight.  
D. There must be no hallucinations, delusions, or depressive stupor.  
F32.3 Severe depressive episode with psychotic symptoms 
A. The general criteria for depressive episode (F32) must be met.  
B. The criteria for severe depressive episode without psychotic symptoms (F32.2) must be met with the exception of 
criterion D.  
C. The criteria for schizophrenia (F20.-) or schizoaffective disorder, depressive type (F25.1) are not met.  
D. Either of the following must be present:  
(1) delusions or hallucinations, other than those listed atypically schizophrenic in F20, criterion G1(1)b, c, and 
d (i.e. delusions other than those that completely impossible or culturally  
DSM IV TR 
Bipolar I Disorder:  
The essential feature of Bipolar I Disorder is a clinical course that is characterized by the occurrence of  
one or more Manic Episodes or Mixed Episodes. Often individuals have also had one or more Major Depressive 
Episodes.  
Episodes of Substance-Induced Mood Disorder (due to the direct effects of a medication, or other somatic treatments 
for depression, a drug of abuse, or toxin exposure) or of Mood Disorder Due to a General Medical Condition do not 
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count toward a diagnosis of Bipolar I Disorder. In addition, the episodes are not better accounted for by Schizoaffective 
Disorder and are not superimposed on Schizophrenia, Schizophreniform Disorder, Delusional Disorder, or Psychotic 
Disorder Not Otherwise Specified. 
Bipolar II Disorder:  
The essential feature of Bipolar II Disorder is a clinical course that is characterized by the occurrence of one or more 
Major Depressive Episodes accompanied by at least one Hypomanic Episode. Hypomanic Episodes should not be 
confused with the several days of euthymia that may follow remission of a Major Depressive Episode. Episodes of 
Substance- Induced Mood Disorder (due to the direct effects of a medication, or other somatic treatments for 
depression, a drug of abuse, or toxin exposure) or of Mood Disorder Due to a General Medical Condition do not count 
toward a diagnosis of Bipolar I Disorder. In addition, the episodes are not better accounted for by Schizoaffective 
Disorder and are not superimposed on Schizophrenia, Schizophreniform Disorder, Delusional Disorder, or Psychotic 
Disorder Not Otherwise Specified. 
Criteria for a Manic Episode 
A. A distinct period of abnormally and persistently elevated, expansive, or irritable mood, lasting at least 1 week (or 
any duration if hospitalization is necessary): 
B. During the period of mood disturbance, three (or more) of the following symptoms have persisted (four if the mood 
is only irritable) and have been present to a significant degree: 
1.inflated self-esteem or grandiosity 
2.decreased need for sleep (e.g., feels rested after only 3 hours of sleep) 
3.more talkative than usual or pressure to keep talking 
4.flight of ideas or subjective experience that thoughts are racing 
5.distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimuli) 
6.increase in goal-directed activity (either socially, at work or school, or sexually) or psychomotor agitation 
7.excessive involvement in pleasurable activities that have a high potential for painful consequences (e.g., 
engaging in unrestrained buying sprees, sexual indiscretions, or foolish business investments) 
C. The symptoms do not meet criteria for a Mixed Episode. 
D. The mood disturbance is sufficiently severe to cause marked impairment in occupational functioning or in usual 
social activities or relationships with others, or to necessitate hospitalization to prevent harm to self or others, or there 
are psychotic features. 
E. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication, or 
other treatments) or a general medical condition (e.g., hyperthyroidism). 
 
Note:  
Manic-like episodes that are clearly caused by somatic antidepressant treatment (e.g., medication, electroconvulsive  
therapy, light therapy) should not count toward a diagnosis of Bipolar I Disorder. 
Criteria for a Mixed Episode 
A. The criteria are met both for a Manic Episode and for a Major Depressive Episode (except for duration) nearly every 
day during at least a 1-week period: 
B. The mood disturbance is sufficiently severe to cause marked impairment in occupational functioning or in usual 
social activities or relationships with others, or to necessitate hospitalization to prevent harm to self or others, or there 
are psychotic features. 
C. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication, or 
other treatment) or a general medical condition (e.g., hyperthyroidism). 
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Criteria for a Hypomanic Episode 
A. A distinct period of persistently elevated, expansive, or irritable mood, lasting throughout at least 4 days, that is 
clearly different from the usual nondepressed mood: 
B. During the period of mood disturbance, three (or more) of the following symptoms have persisted (four if the mood 
is only irritable) and have been present to a significant degree: 
1.inflated self-esteem or grandiosity 
2.decreased need for sleep (e.g., feels rested after only 3 hours of sleep) 
3.more talkative than usual or pressure to keep talking 
4.flight of ideas or subjective experience that thoughts are racing 
5.distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimuli) 
6.increase in goal-directed activity (either socially, at work or school, or sexually) or psychomotor agitation 
7.excessive involvement in pleasurable activities that have a high potential for painful consequences (e.g., 
engaging in unrestrained buying sprees, sexual indiscretions, or foolish business investments) 
C. The episode is associated with an unequivocal change in functioning that is uncharacteristic of the person when not 
symptomatic. 
D. The disturbance in mood and the change in functioning are observable by others. 
E. The episode is not severe enough to cause marked impairment in social or occupational functioning, or to 
necessitate hospitalization, and there are no psychotic features. 
F. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication, or 
other treatment) or a general medical condition (e.g., hyperthyroidism). 
 
Note: Hypomanic-like episodes that are clearly caused by somatic antidepressant treatment (e.g., medication,  
electroconvulsive therapy, light therapy) should not count toward a diagnosis of Bipolar II Disorder. 
Major Depressive Episode 
A. Five (or more) of the following symptoms have been present during the same 2-week period and represent a change 
from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. 
(Note: Do not include symptoms that are clearly due to a general medical condition, or mood-incongruent delusions or 
hallucinations.) 
1.Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feels sad  
or empty) or observation made by others (e.g., appears tearful).  
Note: In children and adolescents, can be irritable mood 
2.Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day (as  
indicated by either subjective account or observation made by others) 
3. Significant weight loss when not dieting or weight gain (e.g., a change of more than 5% of body weight in a  
month), or decrease or increase in appetite nearly every day.  
Note: In children, consider failure to make expected weight gains. 
4.Insomnia or hypersomnia nearly every day 
5.Psychomotor agitation or retardation nearly every day (observable by others, not merely subjective feelings  
of restlessness or being slowed down) 
6.Fatigue or loss of energy nearly every day 
7.Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day  
(not merely self-reproach or guilt about being ill) 
8.Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective account  
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or as observed by others) 
9.Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a  
suicide attempt or a specific plan for committing suicide 
B. The symptoms do not meet criteria for a Mixed Episode. 
C. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of  
functioning. 
D. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a  
general medical condition (e.g., hypothyroidism). 
E. The symptoms are not better accounted for by Bereavement, i.e., after the loss of a loved one, the symptoms persist 
for longer than 2 months or are characterized by marked functional impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic symptoms, or psychomotor retardation. 
 




Table 3. Post hoc t-tests for differences in VALENCE RATINGS. Significant differences are 
highlighted in bold. 
Mildly depressed vs. control T df p value 
Positive 0.397 50 0.693 
Neutral 0.878 50 0.384 
Negative 0.872 50 0.387 
depressed vs. control 
   Positive -1.187 58 0.24 
Neutral -0.447 58 0.656 
Negative -0.327 58 0.745 
mania vs. control 
   Positive 1.628 45 0.111 
Neutral 2.258 6.465 0.062 
Negative -0.854 45 0.398 
mixed vs. control 
   Positive -1.956 45 0.057 
Neutral -1.254 45 0.216 
Negative -0.166 45 0.869 
mildly depressed vs. depressed 
   Positive 1.495 30 0.145 
Neutral 0.916 30 0.367 
Negative 0.884 30 0.384 
mildly depressed vs. mania 
   Positive -1.422 17 0.173 
Neutral -1.497 17 0.153 
Negative 0.897 17 0.382 
mildly depressed vs. mixed 
   Positive 2.396 17 0.028 
Neutral 1.076 17 0.297 
Negative 0.544 17 0.593 
depressed vs. mania 
   Positive -2.631 25 0.014 
Neutral -2.356 7.057 0.05 
Negative 0.626 25 0.537 
depressed vs. mixed 
   Positive 1.31 25 0.202 
Neutral 0.854 25 0.401 
Negative -0.049 25 0.961 
mania vs. mixed 
   Positive 3.014 12 0.011 
Neutral 2.741 7.573 0.027 





Table 4. Medication list of all patients. 
Medication  



















 300mg; 5mg     
2 2x 450mg  300 mg  2x 600mg    
3 225mg  300mg   100mg  
4   4mg   25mg, 150mg 3x 0,5mg 
5   
 
    
6 450, 900mg  300mg  375mg  2x 0,5mg; 10mg 
7 450, 900mg      
 8 2x 450mg     100mg 0,5mg 
9 2x 450mg 2,5mg , 0,5mg 100mg    0,5mg 
10   2,5mg    20mg 
11 450, 900mg  100mg  300mg, SNRI   
 12 2x 450mg    
 
50, 150mg 0,5 
13 225, 450mg    10mg  2x 0,5mg ; 10mg 
14  250mg  2x 600mg    
15  
 
500mg     
16 2x 450mg 75mg 
 
   0,5mg; 20mg 
17 
 
 5mg     
18 2x 450mg  
 
 40mg   
19 2x 450mg  300mg 2x 50mg  75mg  
20 2x 450mg     75mg 10mg 
21 2x 450mg   1200mg  25, 50mg 0,5mg 
22 
 








 24 2x450mg  5mg  150mg  0,5mg 
25 2x 400mg  200mg  150mg   
26 2x 450mg  
 
 300mg 45mg  




28   10mg; 50mg     
29 2x 600mg  300mg     
30   300, 350mg     
31   200mg; 15mg 500, 600mg    
32 675, 900mg  50mg; 2x 2mg 
 
  20mg 
33 450, 675mg  20mg 600, 900mg   30mg 
34   
   
  
35   7,5mg 600, 900mg 300mg   
36   300mg 
 
225mg  0,5mg 
37 900mg  100mg; 10mg 100mg 75mg  
 38 
 
 150mg  300mg  1,5mg 
39 1800mg  
 
  100mg; 150mg 1,5mg; 10mg 
40   300mg 800mg   
 41   2x 2,5mg 2x 25, 75mg   1,5mg; 10mg 
42   10mg  225mg 30mg  
43 900mg  
 
    
44 900mg  300mg     





   





I would like to thank several people.  
I would like to express my special appreciation and thanks to my advisor Professor Dr. 
Andreas Reif, you have been a tremendous mentor for me. I would like to thank you for 
encouraging my research and for allowing me to grow as a research scientist. Your advice on 
both research as well as on my career have been priceless. I would also like to thank you for 
your trust in me and my ideas, and for your friendship. Without you, I would not be writing 
this right now.  
I would also like to thank my committee members, Professor Dr. Paul Pauli, and Dr. Martin 
Herrmann, for serving as my committee members even at hardship. Thank you for your 
advice and your time. 
I would especially like to thank all my coworkers inside and outside the lab at the clinic: 
Antonia, Lena, Aet, Florian, for providing coffee, sweets and a shoulder to cry on, on 
countless occasions. When I thought I wanted to throw in the towel, you were there. I cannot 
believe how lucky I am to have the opportunity to continue working with you, and being 
friends with you. 
Julia, my personal built-in psychotherapist: for always listening to my rants, giving the best 
advice, sharing my dislike of large datasets nobody knows what to do with. For rooming with 
me and the “cold asshole”.  
All the other people in the lab who have seen me turn into rumpelstiltskin over data, routines, 
my computer in general and all other research related problems. Thank you for your patience.  
I would also like to thank all patients, controls, physicians, and all other people involved in 
this thesis. 
I want to thank my parents for always being there, and believing that I can do it. 







Name    Juliane Kopf 
Birthday   08.03.1980 
Education 
2005 – 2010   Study of Psychology at the University Wuerzburg 
2010    Diploma in Psychology from the University of Wuerzburg 
11/2010 – 02/2014  PhD Student, stipend with the Graduate School “Emotions” 
 
First Author Publications 
Kopf J, Schecklmann M, Hahn T, Dresler T, Dieler AC, Herrmann MJ, Fallgatter AJ, Reif A. 
NOS1 ex1f-VNTR polymorphism influences prefrontal brain oxygenation during a working 
memory task. NeuroImage. 2011 Aug 15;57(4):1617-23. 
Kopf J, Schecklmann M, Hahn T, Dieler AC, Herrmann MJ, Fallgatter AJ, Reif A. NOS1 
ex1f-VNTR polymorphism affects prefrontal oxygenation during response inhibition tasks. 
Hum Brain Mapp. 2012 Nov;33(11):2561-71. 
Kopf J, Reif A. Impulsivität in der bipolaren Erkrankung. neuroaktuell. 2012 Oct; 26 (211): 
28-32. 
Kopf J, Dresler T, Reicherts P, Hermann M, Reif A (2013). The effect of emotional content 
on brain activation and the late positive potential in a word n-back task. Plos ONE, 2013 









I hereby confirm that my thesis entitled “Emotion processing and working memory deficits in 
bipolar disorder: interactions and changes from acute to remitted state.” is the result of my 
own work. I did not receive any help or support from commercial consultants. All sources 
and/or materials applied are listed and specified in the thesis. 
Furthermore, I confirm that this thesis has not yet been submitted as part of another 
examination process neither in identical nor in similar form.  
 
 




Hiermit erkläre ich an Eides statt, die Dissertation „Emotionsverarbeitung und 
Arbeitsgedächtnisdefizite in der bipolaren Störung: Interaktionen und Veränderungen im 
Verlauf der Erkrankung.“ eigenständig, d. h. insbesondere selbständig und ohne Hilfe eines 
kommerziellen Promotionsberaters, angefertigt und keine anderen als die von mir 
angegebenen Quellen und Hilfsmittel verwendet zu haben. 
Ich erkläre außerdem, dass die Dissertation weder in gleicher noch in ähnlicher Form bereits 
in einem anderen Prüfungsverfahren vorgelegen hat.  
 
 
Ort, Datum      Signature 
